Development of gel dosimetry for radiotherapy by Smith, Shaun T.
Development of Gel Dosimetry for Radiotherapy 
 
A THESIS SUBMITTED TO 
THE SCIENCE AND ENGINEERING FACULTY 
OF QUEENSLAND UNIVERSITY OF TECHNOLOGY 
IN FULFILMENT OF THE REQUIREMENTS FOR THE DEGREE OF 
DOCTOR OF PHILOSOPHY 
 
 
 
 
 
 
Shaun Smith 
 
Supervisors:  
Dr. Jamie Trapp 
Dr. Kye Masters 
Dr. Scott Crowe 
 
School of Chemistry, Physics and Mechanical Engineering 
Science and Engineering Faculty 
Queensland University of Technology 
 
2017  
2 
 
  
3 
 
Abstract 
 
 
Gel dosimeters are three-dimensional radiation detectors, potentially applicable as dose 
verification tools for use in radiotherapy. Despite extensive research over the last three 
decades, gel dosimeters have yet to achieve widespread clinical acceptance, mainly because 
of three major practical concerns; toxicity of active materials, oxygen sensitivity of dose 
response, and spatial instability of dose information. A number of gel dosimetry systems have 
been developed over the years with differing mechanisms of operation and varying degrees of 
success in alleviating the practical issues inhibiting clinical uptake. The oldest and best 
understood of these systems is the Fricke gel dosimeter. Fricke gels are non-toxic and have a 
strong response to radiation; however, these systems are subject to diffusion of dose 
information which is their primary drawback.  In the pursuit of a more clinically feasible 
three-dimensional dosimeter, this work aimed to reduce diffusion of dose information in 
Fricke gels via chemical manipulation of ingredients. 
 
Fricke gels contain ferrous sulphate in an acidic, aqueous solution with a gelling agent (i.e. 
gelatine, agarose, poly(vinyl alcohol) (PVA) etc.) and a reporter molecule (xylenol orange). 
Upon irradiation, a dose-dependent transformation of ferrous ions (Fe
2+
) into ferric ions 
(Fe
3+
) occurs. Upon this transformation, the ferric ions are chelated by xylenol orange, 
inducing a colour change in the gel. It is hypothesised that by covalently bonding the Fricke 
gel reporter molecule, xylenol orange, with a gelling agent, PVA, that post-irradiation colour 
changes would be less able to diffuse. To test this, the initial gel modifications in this thesis 
involved simple methods that altered commercially sourced xylenol orange and PVA to 
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induce bonding. These methods yielded some success and a synthesis route to PVA partially 
functionalised with xylenol orange was developed. Integrating this molecule into a Fricke gel 
resulted in a diffusion coefficient of 0.129 mm
2 
h
-1
;
 
an 8% reduction in diffusion compared to 
a gel with the same PVA concentration. It was concluded that to improve these results, more 
efficient methods of synthesising the functionalised polymer would need to be developed. 
 
To achieve this, a vastly different synthesis approach was undertaken; small modifications to 
PVA and xylenol orange were made to couple the compounds via a ‘click’ reaction. Specific 
synthesis methods are defined as ‘click’ chemistry when they are reliable, high yielding, 
simple to perform, and create by-products which only require simple filtration to be removed. 
These techniques had proven effective at functionalising polymers in the past, and applied to 
this system was also successful. PVA with azide functionality was produced via 
modifications to published methodology. Xylenol orange was produced in house with 
selective modifications to add an alkyne group. Xylenol orange-substituted PVA was attained 
by bonding the two intermediates via the Huisgen 1, 3-Dipolar Cycloaddition of alkynes and 
azides, and unlike the previous synthesis attempt, achieved complete functionalisation with 
no unbound xylenol orange in the final compound. 
 
The final investigation, to complete this work, incorporated xylenol orange-substituted PVA 
into Fricke gels. Comparing formulations with varied gelling agents and additives showed 
that a gel with good dosimetric properties could be made with a mixture of 10% (w/v) gelatin 
in a 50 mM H2SO4 aqueous solution, with 10 mM glyoxal, 0.1 mM ferrous sulphate, and 0.1 
mM xylenol orange – substituted PVA. Using gelatine as opposed to PVA in the final gel 
offers great practical benefit, as the time and effort required to mix and set gelatine is 
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significantly lower than for PVA. The gels optical density was measured to have a linear dose 
response (r
2
 = 0.9983) from 0 to 32 Gy with an sensitivity of 0.0031 Gy
-1
, an auto-oxidation 
rate of 0.00023 h
-1
, and a diffusion coefficient of 0.132 mm
2 
h
-1
. Incorporating the new 
functionalised polymer provided a considerable improvement to spatial stability, with a 
diffusion rate 56% lower than the previously lowest figure for gelatine Fricke gels. The gel 
also demonstrated a continued linear response when reused, with only a 10% reduction in 
dose sensitivity. This new gel dosimeter represent a considerable development as it marries 
the low diffusion of a PVA gel, with the ease of preparation and reliability typical of gelatin 
based Fricke gels. Although producing xylenol orange – substituted PVA would not be 
practical in a clinical environment due to the laborious synthesis, the availability of the 
functionalised polymer from commercial suppliers would allow for an easy to use, low-
diffusing, reusable three-dimensional dosimeter. This new gel dosimeter realises the aim of 
the project and represents the final product of this work. 
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Chapter 1 
 
Introduction 
 
 
1.1. Research Problem 
 
Cancer is one of the world’s leading causes of death, accounting for 8.2 million deaths in 
2012.
[2] 
As such, extensive research and resources have been devoted to develop techniques 
to fight cancer.  Due to the ever-growing understanding of the impact of radiation to the 
body, radiotherapy has become an increasingly reliable means of controlling tumours in both 
the palliative and curative role.  The most recent radiotherapy techniques, such as 
tomotherapy and arc therapy are capable of delivering highly conformal doses with steep 
field gradients.  This effectively minimizes the amount of normal tissue being irradiated in 
the treatment field, sparing sensitive tissue from overly large doses.   
 
To verify the accuracy of such techniques, it is advantageous to measure the radiation dose 
distribution in three dimensions. Dose verification is an important part of the planning 
process as it provides an independent confirmation that the treatment plan is delivering its 
dose accurately to the target.  Dosimeters such as ionization chambers, thermoluminescent 
detectors (TLD’s) and radiochromic film are effective at quantifying dose but are limited to 
measurements at either a point or in two dimensions.
[3]
 One possible candidate for 3D dose 
measurement is gel dosimeters. 
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Gel dosimeters are comprised of a gel matrix (usually a polymer) permeated with radiation 
sensitive materials.  Upon irradiation, a measurable chemical change is induced in these 
active materials that are held in position by the gel matrix, hence retaining a 3D spatial record 
of the delivered dose. There are several potential advantages of gel dosimeters over other 
dosimetry techniques. On top of having the ability to score dose in three dimensions, the gel 
itself can act as the humanoid phantom, and consequently does not result in dose 
perturbations behind the point of measurement.  Additionally, most gel dosimeter 
formulations show a significant degree of radiological tissue equivalence and can be moulded 
into containers of varying shape allowing the creation of anthropomorphic phantoms and 
accurate modelling of radiation dose distributions.   
 
Over the last three decades of gel dosimetry, the clinical need for 3D dosimeters has changed 
as new radiotherapy technologies and practices have been developed. Today, 3D dosimetry 
has potential application in dose verification of the most complex dose deliveries, as well as 
in the evaluation of positioning errors.   Despite their numerous benefits, there are a number 
of complications associated with gel dosimetry that remain to be addressed, and that are 
inhibiting the routine use of gels in the clinic.  These include:  
1. Issues with diffusion of the active material through the gel matrix in Fricke gels.[4]  
2. Problems arise due to the oxygen sensitivity of polymer gels causing inconsistencies in 
their radio sensitivity.
[5-8]
  
3. One of gel dosimeters’ biggest limitations is a lack of convenience as clinical use can be 
time consuming and hazardous, with some active materials being highly toxic.
[9]
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1.2. Project Aim 
Currently, gel dosimetry requires time and specialized manufacturing facilities for users who 
intend to undertake all steps from gel manufacture to evaluation.  However, this may not be 
necessary and potentially a ‘standard’ dosimeter could be shipped from manufacturers to 
users. Commercial suppliers of gel dosimeters do exist, however each product is still subject 
to one or more of the aforementioned limitations. The development of gels, which are non-
toxic, immune to the concentration of oxygen and are not affected by diffusion, will aid in 
their implementation and make gel dosimetry more widely accessible. As such, the aim of 
this project is to develop a novel gel dosimeter that conforms to the above criteria. 
 
1.3. Thesis Structure and Overview 
The thesis is organised in the following structure: 
 Chapter 1 provides a brief introduction to the research problem, outlines the overall 
aim of the work, and lays out the thesis structure, identifying the content of each 
chapter. 
 Chapter 2 reviews the relevant literature, firstly with a broad discussion of 
radiotherapy to establish the role of gel dosimetry in the clinic. Then, the various gel 
dosimetry systems are detailed, along with the strengths and limitations of each as 
practical, clinical, dosimeters. 
 Chapter 3 details a brief investigation aimed at optimising the measurement of 
diffusion in gels. The work compares half-field blocking techniques to minimize the 
beam penumbra. The optimal blocking technique is used to perform gel diffusion 
measurements in subsequent chapters. 
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 Chapter 4 identifies an avenue to improve on the practicality of the PVA-Fricke 
hydrogel by reducing diffusion of dose information. The paper acts as a proof of 
concept that functionalising polymers with reporter molecules in gels can reduce 
diffusion, laying the groundwork for future studies. 
 Chapter 5 expands on the work in the previous chapter by developing a method of 
synthesising a new molecule which covalently bonds the Fricke gel reporter molecule 
to PVA. 
 Chapter 6 incorporates the molecule synthesised in the previous chapter into a Fricke 
gel system. A number of gel formulations are evaluated to optimise the dosimetric 
properties of the system. Upon identifying the optimal formulation, a more 
comprehensive characterisation of the gel is performed. The gel developed here 
represents the final product of this work. 
 Chapter 7 concludes the thesis, identifying key outcomes of the work and issues for 
future research. 
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Chapter 2 
 
Background and Literature Review 
 
 
The following chapter encompasses the relevant work already completed in this field together 
with fundamental physical and chemical processes at the basis of this investigation. It is 
separated into 2 primary focus topics. Section 2.1 gives a general outline of radiotherapy, and 
highlights the necessity of three-dimensional dosimetry techniques for dose verification. 
Section 2.2 focuses specifically on the various types of gel dosimeters being researched. This 
includes a discussion of their strengths, limitations, mechanisms of operation, and various 
employed methods of dose read-out. 
 
2.1. Radiotherapy 
Radiotherapy is the medical technique of controlling or killing cells with ionizing radiation, 
and is used in the management of cancer.  Particles (including photons, electrons, protons and 
neutrons of sufficient energies) are used to treat cancer by damaging the DNA within the 
tumour cells, making them unable to divide and grow. There are three main modes of 
radiotherapy, each distinguished by the position of the radiation source with respect to the 
body; external beam radiotherapy (EBRT) uses a radiation beam incident from outside the 
body (eg. linear accelerator, 
60
Co source), brachytherapy uses sealed radioactive sources 
placed precisely in the area requiring treatment, and radioisotope therapy
[10]
 utilizes 
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radioisotopes delivered by infusion in the bloodstream or oral ingestion. The focus of this 
work is the underlying principles of EBRT. 
 
2.1.1. External Beam Radiotherapy 
A conventional course of EBRT delivers a prescribed radiation dose to a given volume of 
tissue via one or more radiation fields from a linear accelerator (linac). To accomplish this, 
treatment planning systems (TPS) generate dose maps (see Figure 2.1) detailing the intended 
delivery using information regarding the target volume contained in CT scans, along with 
user specified minimum and maximum dose requirements. As computing power has 
advanced over the last few decades, more sophisticated and precise techniques have been 
developed to deliver the dose to a more highly defined volume. 
 
Compared to initial EBRT methods, significant improvements have been achieved using 
modern techniques including image-guided radiation therapy (IGRT), intensity modulated 
radiation therapy (IMRT), volumetric modulated arc therapy (VMAT), helical tomotherapy, 
stereotactic body radiation therapy (SBRT) and radiosurgery (SRS), and particle therapy. To 
demonstrate the highly conformal dose delivery of some of these techniques, Figure 2.1 
compares IMRT and VMAT treatment plans around the head and neck. Relative to 
conventional EBRT methods, the IMRT plan provides a significant reduction in dose to 
healthy tissue; however the dose map obtained through VMAT shows further improvements, 
almost completely eliminating any dose to the cervical spine cord (dark area near the centre 
of the cross-section). 
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Despite this, the field of radiation oncology has reached a critical point in its development 
whereby the planning systems and treatment units are capable of delivering highly conformal 
doses with steep field gradients, yet dosimetry systems have not been developed to a 
sufficient level to allow accurate 3D verification which is routine and easy to use.
[11]
 
Inaccuracies in dose delivery along with geometric uncertainties (which in radiotherapy 
translates to dosimetric uncertainties) can be detrimental to patient health; e.g. a 5% 
difference in the delivered dose may result in changes in the order of 10-20% in tumour 
control probability and 20-30% in normal tissue complication probability.
[12, 13]
 It therefore 
follows that dose verification is an imperative quality assurance component of the treatment 
planning process.  
 
2.1.2. Dose Verification Methods 
There are a number of techniques used for dose verification of radiotherapy treatments 
employing a variety of dosimeters including ion chambers, thermoluminescent dosimeters 
Figure 2.1: A comparison of treatment plan dose maps from Varian for IMRT and Arc 
Therapy.
[1]
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(TLDs), radiochromic film, Monte Carlo modelling (computational dosimetry) and gel 
dosimetry. 
The use of ion chambers is prevalent in radiation oncology as they provide accurate 
dosimetric measurements stemming from the well-understood relationship between ionization 
and dose. For treatment verification, an array of small ion chambers can be manufactured 
allowing a 2D map of the dose to be acquired.
[14, 15]
 However, this is limited in practice as the 
resolution of the array is restricted by the relatively large size of the ion chamber (i.e. ~1 cm 
diameter), in addition to issues of high cost and time-consuming data collection. 
 
Like ion chambers, TLDs can be arranged in a water equivalent phantom to produce a 2D 
post irradiation dose distribution.  Despite being easy to calibrate for quicker measurements, 
TLDs are prone to fading responses over time and as with ion chamber arrays are limited to 
point by point, low spatial resolution dose recording.
[16]
 
 
Conversely, radiochromic film provides a continuous 2D dose distribution and is 
exceptionally useful in relative dosimetry but despite this, it can be difficult to extract 
absolute dose values from the film. It has been shown that a quasi-3D dose distribution can 
be obtained by stacking film inserted between slices of a water equivalent phantom material. 
Measurements of an IMRT dose distribution using film separated by 1 mm sheets of water 
equivalent material had a 98% agreement with treatment planning calculations; however 
performing such measurements is very costly using multiple slices of film which cannot be 
reused.
[17, 18]
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Monte Carlo (MC) simulations employ random numbers to sample outcomes of stochastic 
processes. This allows the simulation of particle transport in a radiation beam by sampling 
particle interaction cross-sections. With the development of faster computational systems and 
more efficient MC algorithms, the use, accuracy, and versatility of Monte Carlo modelling in 
treatment plan verification has increased dramatically.
[19, 20] 
However, due to the complexity 
of IMRT and VMAT treatment plans, excessive computational times are often required to 
simulate with adequate accuracy. MC simulations, being computational by nature, do not 
provide experimental verification of a treatment, and are unable to capture the myriad issues 
unique to a real-world treatment such as positional errors etc.. 
 
A theoretical verification of a practical treatment is fundamentally deficient and as such, a 
suitable 3D method of verifying dose delivered during complex treatments such as IMRT and 
VMAT is desired which can reliably reproduce the dose delivered to a target area cheaply 
and quickly. It is considered that radiosensitive gels are an appropriate candidate for this 
application. 
 
2.2. Gel Dosimetry 
The first step towards the development of gel dosimetry came in 1927 when Hugo Fricke and 
Stern Morse created a ferrous sulphate solution which when irradiated would oxidise Fe
2+
 to 
Fe
3+
.
[21]
 This would later become known as the Fricke solution; the basis of the Fricke gel 
dosimeters and a chemical dosimetry system still used in primary standards labs due to its 
high accuracy.  Radiochromic gels for chemical dosimetry of ionizing radiation were reported 
in 1951 using spectrophotometer measurements to determine radiation induced colour 
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changes,
[22]
 but without the advent of digital computers and optical computed tomography, 
3D readout was not possible. Modern gel dosimetry started with the suggestion of using 
hydrogels to measure dose distributions in 3D by Gore and Kang in 1984, which used 
magnetic resonance imaging (MRI) to measure the post-irradiation oxidation of ions in the 
Fricke solution.
[23]
 Gore et al. then proposed that the solution be infused into a gel to record 
spatial distribution of radiation doses, initiating a widespread proliferation of research into 
gel dosimetry. Since then, research has yielded a variety of gel dosimetry systems, which can 
be categorized into three main groups; Fricke (as above),
[4, 23-33]
 Polymer,
[5-8, 34-40]
 and 
Radiochromic gel dosimeters.
[41-47]
 
 
2.2.1. Fricke gel dosimeters 
Fricke gels are based on adding gelling agents (such as gelatin, agarose or PVA) to the Fricke 
solution; an acidic oxygenated aqueous solution of ferrous ion (Fe
2+
).  The dosimetric basis 
of the Fricke solution is provided by the dose dependent transformation of ferrous (Fe
2+
) ions 
into ferric (Fe
3+
) ions.
[48]
 When the solution is irradiated, water decomposition occurs: 
H2O → H• + HO• 
Hydrogen atoms produced react with oxygen to produce the hydroperoxy radical: 
H• + O2 → HO2• 
A number of subsequent reaction pathways lead to the conversion of ferrous to ferric ions, as 
below: 
Fe
2+
 + HO• → Fe3+ + OH− 
Fe
2+
 + HO2• → Fe
3+
 + HO2
−
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HO2
−
 + H3O
+
 → H2O2 + H2O, and 
Fe
2+
 + H2O2 → Fe
3+
 + OH• + OH− 
The change in ferric ion concentration is related to the radiation dose by:
[48]
  
Δ[𝐹𝑒3+] =
𝐷. 𝐺(𝐹𝑒3+). 10𝜌
𝑁𝐴. 𝑒
 
Where: 
D is the dose,  
G (Fe
3+
) is the chemical yield of Fe
3+
 (expressed in ions produced per 100 eV), 
ρ is the density in kg L-1,  
NA is Avogadro’s number and 
e is the number of Joules per electron volt. 
In order for 3D dose measurements to be extrapolated, an effective method of determining 
the concentration of ferric ions must be utilized.  The first reported systems employed MRI to 
detect and quantify ferric ion concentrations within the gel matrix.
[23]
 Unfortunately, the poor 
spatial stability of Fricke gels due to diffusion of Fe
3+
 ions constrains the permissible time 
between irradiation and measurements,
[4]
 causing the method to be significantly more 
difficult for employment by hospital staff. Limited success in reducing diffusion rates is 
obtained using different gelling agents (gelatin, agarose, sephadex and polyvinyl-alcohol) and 
chelating agents such as xylenol orange, which induces colour changes that permit optical 
imaging.
[6, 26]
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Chelators are organic chemicals that form two or more coordination bonds with a central 
metal ion. The xylenol orange indicator is well suited for Fricke gel dosimetry, offering a 
number of advantages as a method of detecting ferric ions in these dosimeters.  As the Fe
2+
 
ion is oxidized into the Fe
3+
 ion, there is an inherent increase in the electropositivity of the 
ion allowing the co-ordination of the Fe
3+ 
ion by the xylenol orange molecule.  This results in 
an oxidative ring opening/closing, which changes the absorption spectrum of visible light and 
an evident colour change at the frequency of visible light.
[27-31, 49]
 The first major benefit of 
this is the allowance of optical computed tomography imaging, eliminating the need for 
impractical and expensive MRI equipment.  On top of this, they improve the stability of the 
spatial dose information by reducing the diffusion coefficients of the iron ions,
[32]
 which is 
one of the main limitations for Fricke gel dosimetry. Best results have been obtained by the 
PVA xylenol orange Fricke dosimeters proposed by Chu et al.
[24, 25]
 Their work reports a 
diffusion coefficient of 1.4 × 10
-3
 cm
2 
h
-1
, about one order of magnitude less than that of 
conventional Fricke gels and about half of that of the agarose and gelatin gels with chelating 
agents.
[4]
 Thus, with PVA gels the experiment has a 10 hour window in which to probe the 
dose distribution. 
 
Fricke gels are attractive for 3D dosimetry as they are easy to prepare and readout, are tissue 
equivalent over a very large photon energy range, and give reproducible results.
[4]
 However, 
like other gels used in dosimetry, Fricke gels are sensitive to conditions during preparation, 
irradiation and read-out (for example, impurities and temperature).
[4]
 The chemical yield (G 
value) of Fricke solutions is influenced by oxygen, as it is required to produce the 
hydroperoxy radical (i.e. G= 15.5 ±0.2 ions/100 eV for a dosimeter in equilibrium with air 
and G= 8.2±0.3 for an oxygen-free dosimeter).
[33, 48, 50, 51]
 The development of more stable 
Fricke systems together with the advent of techniques that enable determination of the 
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radiation dose more quickly, clearly indicate that Fricke gel dosimetry has a continuing role 
in radiation therapy in the clinic. 
 
2.2.2. Polymer gel dosimeters 
Polymer gel dosimeters are another widely researched set of 3D gel dosimeters. They contain 
water and gelatin, along with monomers and crosslinkers that polymerize in response to free 
radicals generated by water radiolysis.
[6]
 The first polymer gel dosimeters emerged in 1993 as 
Maryanski et al. published two papers reporting investigation of a gel infused with radiation-
sensitive polymers which give rise to an MRI signal after irradiation, and which does not 
suffer the diffusion problems of Fricke gel dosimeters.
[52, 53]
 Subsequently, a variety of 
different monomers and crosslinkers have been tested for use in polymer gel dosimeters all of 
which operate on a well-understood dosimetric basis (See figure 2.2).
[6]
 This begins with the 
decomposition of reactive intermediates (R•) via radiolysis of water molecules in the gel: 
H2O 
𝑖𝑟𝑟𝑎𝑑𝑖𝑎𝑡𝑖𝑜𝑛
→         2R• 
The radicals initiate the polymerization of monomers (M) by reacting with the monomer. The 
initiation step can be written as follows:  
R• + M → M1• 
The growth of the polymer continues by chain propagation reactions in which the polymeric 
radicals react further by adding monomers or bonding via crosslinking groups that are present 
on other polymer chains. The general case in which a polymer radical with n monomer units 
reacts with a monomer or a dead polymer chain containing m monomer units is shown below:  
Mm• + Mn → Mn+m• 
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Termination of the polymerization reaction occurs by the reaction of two radicals by either 
combination or disproportionation, or by the reaction of reactive intermediates (R•) with 
growing polymer chains. 
 
 
Figure 2.2: Schematic representation of the interaction between different chemicals in a 
polymer gel dosimeter.
[8]
 
The amount of free radicals released during the radiolysis of the water within the gel is 
proportional to the dose received by the gel dosimeter.  Consequently, the resultant amount of 
polymer formed is also proportional to dose until an upper limit is reached.  After the upper 
dose limit is reached, consumption of monomers results in a saturation effect and the amount 
of polymerization plateaus after the optimum range is exceeded.
[34]
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One of the major difficulties encountered by researchers when making polymer gel 
dosimeters is oxygen contamination. Oxygen consumes primary free radicals produced by 
water radiolysis and inhibits the growth of polymer radicals.
[5, 7]
 Traditional polymer gel 
dosimeters were manufactured in oxygen-free glove boxes to inhibit oxygen contamination.
[5]
 
An innovation on these systems that responded well in normal atmospheric conditions was 
the MAGIC gel (Methacrylic and Ascorbic acid in Gelatin Initiated by Copper) developed by 
Fong et al.
[54]
 Contrary to previous polymer gels, the ascorbic acid-metal complex in MAGIC 
gels utilised oxygen to generate free radicals which in turn initiated polymerization. 
Following this development, most polymer gel dosimeters are ‘normoxic’ dosimeters that are 
manufactured in the presence of air. The most recent systems use an oxygen scavenger such 
as tetrakis hydroxymethyl phosphonium chloride (THPC) to remove oxygen that is initially 
dissolved in the gel solution.
[35-37]
 
  
Further issues arise when considering the convenience and safety of clinical polymer gel 
dosimetry.  The monomers required to manufacture polymer gels are extremely hazardous. 
Converse to the PVA used in some Fricke gels, acrylamide (which is the most studied due to 
practical concerns; namely dose-rate sensitivity and temperature sensitivity) is a neurotoxin 
and suspected carcinogen.  In some recent dosimetry studies, acrylamide has been replaced 
with N–isopropyl acrylamide (NIPAM), which has lower toxicity than acrylamide, is less 
likely to be ingested via inhalation due to its lower volatility and is less able to pass through 
human skin.
[35, 38-40]
 Despite this, proper safety precautions (i.e. preparation in a fume hood 
and use of gloves and goggles) still need to be used when manufacturing these dosimeters, 
complicating their use in a hospital setting or by a non–expert/chemist.  
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Polymer gels have a number of benefits as 3D dose verification tools; they have a good 
spatial stability and can easily be read out via several imaging techniques (MRI, Optical CT, 
X–ray CT). However, the progress of polymer gel dosimetry is limited by the time 
consuming schedule required to take measurements (i.e. post-irradiation development time is 
much longer than Fricke gels), the toxicity of monomers used in manufacturing, and the high 
oxygen sensitivity (issues B and C).   
 
2.2.3. Other Radiochromic 3D dosimeters 
Research into alternate radiochromic 3D dosimeters is a more recent field of study than 
polymer or Fricke gels.  These dosimeters mostly consist of dyes emulsified in a 
hydrogel/polymer matrix.  The dye molecules react with free radicals generated by water 
radiolysis, changing colour for optical readout.  Radiochromic 3D dosimeters are promising 
tools within three–dimensional dosimetry since they are easy to make, insensitive to oxygen, 
have favourable diffusion rates, and possess good properties for optical readout due to a non-
scattering dose response (unlike polymer type gels). Three promising radiochromic systems 
are the Micelle,
[41, 42]
 PRESAGE,
[43, 44]
 and Genipin 
[45-47]
 dosimeters, all of which operate by 
varying mechanisms. These 3D dosimetry systems are in relative infancy compared to Fricke 
or polymer type gels and therefore need further investigation and development before 
widespread clinical implementation is possible. 
 
2.2.4. Dose Read-out Methods 
Once a gel phantom has been irradiated, an appropriate method is required to extract dose 
maps from the induced chemical change in the gel. Three major techniques have been 
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reported successful in this task. The first to be used was MRI, for which a number of gel 
compositions presently being evaluated have well understood responses.
[5, 23, 32, 35, 52, 53]
 Using 
a commercial MRI scanner, radiation induced changes in a gel (either oxidation of ferrous 
ions in a Fricke gel or polymerization in a PAG gel) can be acquired from a map of the R2 
values determined through measurements of the water proton NMR transverse relaxation 
time T2 (R2
 
= 1/T2). Although well researched, the quality of the imaging process is 
influenced by several factors, including inconsistencies in temperature, inhomogeneities of 
the magnetic field, and the presence of eddy currents.
[55-57]
 Due to widespread use of MRI 
scanners in today’s hospitals and the excessive cost of their operation, justifying the time to 
scan gel dosimeters may be difficult for hospital administrators. 
 
X-ray CT has also been investigated for use in scanning polymer gel dosimeters and found as 
a viable tool in this capacity. The formation of polymer chains increases the physical density 
of the gel, such that the resulting change in attenuation coefficient can be observed by a CT 
scanner.
[58-60]
 Since X-ray CT is such a well-established imaging technique, and nearly all 
hospitals practicing radiotherapy have access to a CT scanner, this modality has obvious 
advantages. Nevertheless, the process of polymerization has only a small effect on the 
attenuation coefficient of the gel yielding low signal to noise ratios (SNRs) in images. 
Additionally, the process of taking a CT scan will contribute to the dose in the gel, potentially 
voiding the validity of the measurement.
[61]
 Furthermore, being limited to only polymer gel 
measurements eliminates X-ray CT as a feasible modality for read-out of any other gel 
dosimeters.  
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Evidently, the aforementioned imaging techniques are quite expensive and their use in a 
hospital setting is tightly scheduled to process as many patients as possible. Therefore, a 
scanning modality that is independent of normal hospital operations, while having a low cost 
to purchase and operate would be optimal for the purpose of gel readout. Optical CT 
Scanners match these criteria, exploiting optical density changes in gel dosimeters to obtain 
dose maps. Two groups of optical CT scanners have been built; one is based on a single laser 
source coupled to a single photodiode detector and the other uses an incoherent broad light 
source and a large area detector such as a CCD camera. A number of mechanical 
configurations have been designed since the optical CT scanners inception in 1996,
[62]
 
resulting in varying runtimes and image resolutions. Based on availability, the scanner used 
in the work of Chapter 4 is the MGS Research IQScan Optical CT Scanner,
[63]
 a single 
laser/photodiode scanning system which required approximately 45 mins to obtain a full 3D 
scan with 0.5 mm spatial resolution. The investigations of Chapter 6 utilised a cone 
beam/CCD array system; the Vista Optical CT scanner (Modus Medical Devices Inc., 
London, Canada). This system provided a significant reduction in scanner times, taking less 
than 5 minutes for 0.5 mm resolution 3D scans. 
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Chapter 3 
 
Optimization of half field penumbra for diffusion 
measurements 
 
 
In the development of new gel dosimeters, several characterisation studies are generally 
undertaken, including dose response and stability, manufacturing conditions, calibration 
effects and spatial stability.
[37, 64-67]
  To characterise the rate of diffusion in gel dosimeter 
candidates, dose gradients are measured across the edge of a half-blocked field at varying, 
post-irradiation intervals. In other words, the experimentally determined diffusion coefficient 
is a calculation of the loss of edge sharpness as a function of time after irradiation.
[68]
  
 
However, when conducting half-field irradiations, it is apparent that scatter from shielding 
lead blocks together with beam divergence could contribute to an inherent beam penumbra. 
In turn, this penumbra may appear to be diffusion of the dose distribution recorded in a gel. 
Thus, to ensure accurate measurements, the width of the penumbra should be minimized. 
Across the numerous diffusion studies that have been performed, no consistent irradiation 
technique has been used to maximize the sharpness of the half-field edge.
[42, 65, 68-73]
 And, 
although a protocol has been developed which minimizes the effects of initial penumbra,
[70]
 it 
may still be useful to determine how best to produce a half-blocked field using a 6 MV linear 
accelerator. This work aims to achieve this by establishing the inherent penumbra shape and 
width, for various field-blocking techniques. The work from this chapter has been published 
in the Journal of Physics: Conference Series. 
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3.1. Methodology 
 
3.1.1. Half Field Blocking Set-ups 
This work involved measurements of the 10-90% beam penumbra from a Varian Clinac 600C 
(Varian Medical Systems, Palo Alto, USA) linear accelerator using 20 pieces of EBT2 film. 
All irradiations used a 6 MV photon beam with an 11 cm solid water backscatter layer. The 
remaining film pieces were evenly separated into two groups to take measurements at 85 cm 
and 100 cm SSDs. At each SSD, 100MU were applied for 5 different field-blocking set-ups 
with film placed on the surface and at a depth of 4 cm (figure 3.1). The studied techniques of 
half-blocking fields were: 
1. Upper jaw on the central axis (CAX) 
2. Lower jaw on CAX, to provide a reduction in beam divergence from setup 1 
3. Lower jaw on CAX, with 10cm lead block placed 1 mm behind light field edge, to clean 
up the jaw penumbra 
4. 10 cm Lead shield only, as utilised in a number of published diffusion studies[42, 69, 71]  
5. Lower jaw on CAX, with 10 cm lead block placed 1 mm over light field edge, so lead 
collimates the field and jaw reduces lead transmission and scatter from setup 4. 
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Figure 3.1: A schematic of the five half-field blocking techniques, which were investigated. 
 
3.1.2. Penumbra Measurements 
The relative dose to EBT2 film was determined according to the protocol outlined in Kairn et 
al.
[74]
 in order to minimize the effects of film heterogeneity and scanner output variations. 
Each piece of irradiated film was scanned before and after irradiation to correct for any film 
heterogeneities. To account for overall scanner output variation from one scan to the next, the 
ratio of the mean pixel value in an unexposed piece of film was calculated, before and after 
the other pieces of film were irradiated. Red channel images for the pre-scan and post- scan 
data were obtained and the net optical density change due to dose deposition was calculated. 
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From these corrected images, OD profiles were obtained across the half field dose gradient 
using ImageJ. To eliminate noise, a 3-point moving average was applied to each profile. The 
penumbra was taken as being 10% from either extent of the range of optical densities covered 
by the profile as demonstrated in figure 3.2. 
 
 
Figure 3.2: A typical noise reduced half-field profile obtained from the EBT2 film. The 
penumbra is obtained between points, 10% of the range of OD values from the maximum and 
minimum. 
 
3.2. Results and Discussion 
Table 3.1 shows the measured 10-90% penumbra (in cm) for the 5 different half-field setups 
for SSDs of 85 and 100 cm at both surface and depth. Note that the uncertainty due to 
limitations of scanner resolution is ± 0.02 cm for all values. 
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SSD 
(cm) 
Set-up 1 Set-up 2 Set-up 3 Set-up 4 Set-up 5 
Surface Depth Surface Depth Surface Depth Surface Depth Surface Depth 
85 0.95 0.67 1.24 0.67 0.56 0.56 0.53 0.53 0.64 0.56 
100 1.31 0.71 1.24 0.74 0.99 0.64 0.92 0.53 0.88 0.56 
Table 3.1: 10-90% penumbra measurements (cm) for the various half-field blocking set-
ups investigated. The highlighted data points are the most important for analysis as this 
depth is where most half-field measurements are performed. 
 
For almost all arrangements, the penumbra at depth is less than that on the surface. This 
broadening effect at the surface may be attributed to electron contamination and low-energy, 
obliquely-scattered photons which are filtered out within the first couple of cm of water. 
Additionally, measurements at the lower SSD of 85 cm all yield lower penumbra widths than 
those at the 100 cm SSD. This is clearly a result of beam divergence, widening the field as 
distance to the source increases. As almost all measurements involving half-fields are taken at 
depth, it is prudent to compare the penumbra widths at depth to evaluate which set-up is best 
in practice. 
 
Accordingly, observation of the highlighted cells shows that the blocking systems involving 
the lead block (i.e. 3,4, and 5) had clearly lower penumbra widths than those that did not (1 
and 2). As beam divergence evidently provides a significant contribution to the penumbra, 
these lead blocks act to collimate the divergent photons. Beyond this, set-up 4 provides the 
best results for penumbra reduction using lead only with a width of 0.53 ± 0.02 cm. This is 
somewhat counterintuitive, as it would seem that the addition of the lower jaw as in system 5, 
would reduce lead transmission and scatter therefore minimizing the penumbra. However, the 
difference in penumbra width between set-ups 3, 4, and 5 is within the range of the combined 
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uncertainty. Furthermore, this uncertainty cannot account for the inherent noise in OD 
profiles of the EBT2 film. Therefore, if further resolution is required for these results, it is 
suggested that Monte Carlo measurements should be made to accurately characterize the 
penumbra width for these set-ups. 
 
3.3. Conclusions 
Measurements of half-field beam penumbra were taken using EBT2 film for a variety of 
blocking techniques. It was shown that minimizing the SSD reduces the penumbra as the 
effects of beam divergence are diminished. The addition of a lead block directly on the 
surface provides optimal results with a 10-90% penumbra of 0.53 ± 0.02 cm. Having attained 
this result, subsequent diffusion measurements will incorporate the lead block when 
performing the half-field irradiation.  
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Chapter 4 
 
Initial investigations of functionalised PVA in Fricke 
dosimeters 
 
 
Analysing the various existing gel dosimeters, it was decided that the most promising yet still 
manipulable system was the Fricke-xylenol orange dosimeter. Unlike other gels, this 
dosimeter has no toxic ingredients, while still maintaining a high, linear, dose-rate and energy 
independent response with easy read-out via optical CT or MRI. The only drawbacks of the 
system are darkening of the gel through auto-oxidation of ferrous ions, limiting the shelf life 
after preparation (typically a few days to a week), and the diffusion of dose information 
which is detrimental to dosimetric accuracy. A number of additives have been researched in 
previous studies to reduce the auto-oxidation effect in Fricke gels.
[71, 75]
 These efforts have 
increased the shelf life to allow use weeks and in some cases over a month after preparation. 
The issue of diffusion, however, has yet to be alleviated without adversely impacting other 
dosimetric properties of the system. 
 
Prior to this work, the best diffusion results in Fricke gels were obtained by Chu et al. in their 
PVA xylenol orange-Fricke dosimeter. Although this system achieved a large reduction in 
diffusion, the use of PVA as the gelling agent resulted in difficult gel mixing (due to the high 
viscosity of PVA), as well as poor optical properties (as PVA scatters). With this in mind, 
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this work sought to reduce diffusion via a different approach than simply altering the gelling 
agent; the incorporation of a functionalised polymer.  
 
As a pilot study for this idea, the work in this chapter aimed to further reduce the diffusion 
rates obtained in the PVA xylenol orange-Fricke dosimeter by using simple chemical 
synthesis methods to partially or quantitatively bond the xylenol orange compound to the 
PVA gel matrix. It was hypothesised that after this modification, the chelating agent (xylenol 
orange) would be less able to diffuse through the gel, and dose distributions (measurable by 
the colour change of xylenol orange) would be more spatially stable. A number of initial 
synthesis experiments were conducted (see Appendix A) which had poor results, however 
these lead to the development of a method which partially bound xylenol orange to PVA.  
 
This method was informed by the research of Fan et al. whereby xylenol orange 
functionalised silica gel was manufactured using a diazonium compound.
[76]
 Here, the 
method outline by Fan et al. is modified suitably to account for the differing properties of 
PVA to silica gel (i.e. molecular weight, solubility, tendency to polymerise etc.). The 
synthesis of xylenol orange-functionalised PVA is detailed in this chapter along with a 
number of measurements on the resulting gel dosimeter. The work detailed in this chapter has 
been published in Medical Physics. 
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4.1. Methods 
4.1.1. Xylenol orange functionalised PVA preparation 
The process for preparing xylenol orange functionalised PVA is shown in figure 4.1 and was 
conducted in accordance with methods described by Fan et al.
[76]
 Fully hydrolyzed PVA (10 
g, molecular weight 89000–98000, Sigma Aldrich, Sydney) was dried under high vacuum for 
1 hour at 80 °C to remove any absorbed water. The dried PVA was benzoylated at 50 °C in a 
sealed flask under argon with 180 mL of a solution in chloroform containing p–nitrobenzoyl 
chloride (6 g, 98%, Aldrich) and triethylamine (6 mL, Aldrich). The reaction was allowed to 
run for 48 hours, after which the product (I) was filtered and washed with chloroform (300 
mL) under argon, and then dried under vacuum. The dried product (I) was subsequently 
mixed with 5% sodium dithionite (240 ml; technical grade, 85%, Aldrich) in a sealed flask 
under argon at 45 °C for 24 hours. After filtering, washing with cold water (300 mL), and 
drying, the product (II) was diazotized for 1.5 hours at 0–5 ◦C under argon, with aqueous 
NaNO2 (400 mL, 2% w/v) in aqueous acetic acid (1% v/v). The resulting diazonium salt (III) 
was once again filtered, washed with cold water, and dried. The dried diazonium salt was 
mixed with aqueous solution containing xylenol orange (5 g of the disodium salt, in 300 mL 
H2O, Aldrich) in a sealed flask at 80 ◦C for 30 minutes. Once a solution was formed, the 
vessel was returned to room temperature and allowed to stir for 24 hours. To extract the 
xylenol orange functionalised PVA from this solution, ethanol was slowly added to the 
mixture while vigorously stirring to form a yellow, fibrous precipitate. This solid phase was 
filtered and washed with ethanol and water until the filtrate was clear (showing no 
characteristic colour of xylenol orange). The solid was then dried in a lyophiliser for 48 hours 
to obtain the xylenol orange functionalised PVA (XO–PVA). The degree of functionalization 
achieved using this method is discussed in Section 4.2.5. 
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Figure 4.1: Reaction scheme to produce xylenol orange functionalised PVA. 
 
4.1.2. XO–PVA gel production 
The final gel formulation was: XO-PVA (20% w/v), sulfuric acid (50 mM) and ferrous 
sulfate (0.4 mM). A XO-PVA solution (24% w/v) was made in a flask of aqueous sulfuric 
acid (50 mM) while being stirred and heated on a hotplate to 65 °C. Once all XO-PVA was in 
the reaction vessel, the solution was raised to a temperature of 95 °C with a stopper used to 
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minimise evaporation. Meanwhile, a solution containing ferrous sulphate heptahydrate, (2.4 
mM Sigma Aldrich, Sydney) in aqueous sulfuric acid (50 mM) was prepared. The XO-PVA 
was fully dissolved after 3 hours, indicated by a translucent solution, after which the 
temperature was dropped to 55 °C. Subsequently, five parts of the XO-PVA solution was 
mixed with one part of the ferrous sulfate solution to make a final 0.4 mM ferrous ion 
concentration in a 20% XO-PVA solution. Stirring of this mixture was continued for 30 min 
before the gel was poured into 1 cm plastic cuvettes and 4.5 cm diameter PET jars for storage 
at 2 °C.  
 
4.1.3. PVA-FX hydrogel production 
To conduct comparative measurements, the original PVA-FX hydrogel was also made using 
the method outlined in Chu et al. The gel formulation used had a final concentration of 20% 
w/v PVA, 0.4 mM ferrous sulphate and 0.4 mM xylenol orange in 50 mM aqueous sulfuric 
acid. 
 
Figure 4.2: Images of half-field irradiated cuvettes (20 Gy) to demonstrate how each gel 
appears with and without irradiation. Note that for XO-PVA, the unirradiated gel is darker 
yet the contrast achieved post irradiation is lower than PVA-FX gel. 
XO-
PVA 
Gel 
PVA-
FX Gel 
52 
 
4.1.4. Dose response measurements 
Dose response curves were obtained by irradiating cuvettes, which were placed on top of 11 
cm Virtual Water (JRT Associates, Elmsford, USA), covered at a depth of 1.5 cm by Virtual 
Water, and positioned between sheets of Virtual Water placed laterally to ensure dose 
homogeneity. Irradiations were performed using a 6 MV photon beam from an Elekta Precise 
Linac (Elekta, Crawley, UK) and a Varian EX Clinac (Varian Medical Systems, Palo Alto, 
USA) with an SSD of 100 cm. For comprehensive dose response measurements of the XO-
PVA gel, cuvettes were irradiated with doses ranging from 0 to 150 Gy. To perform 
comparative measurements in the linear region, FX-PVA gel cuvettes were irradiated from 0 
to 30 Gy. To maximise signal to noise ratios and scanning resolution, the optical densities 
(ODs) of the gels were measured using the green channel of an Epson Perfection V700 
flatbed scanner in absorption mode. All OD values were obtained through the 1 cm path 
length defined by the cuvette dimensions with an imaging resolution of 266 dpi. The 
reference intensity for flatbed scanner measurements were found by performing a blank pre-
scan and measuring the pixel values across the same area as the irradiated gel cuvette. 
4.1.5. Reaction rate measurements 
One cuvette of each gel was irradiated to 20 Gy using the protocol outline above for the dose 
response measurements. The gel samples were scanned at room temperature every 10 
minutes from 20 to 100 minutes post-irradiation using the flatbed scanner. 
4.1.6. Gel stability measurements 
One cuvette of each gel was left un–irradiated and stored at 2 °C, minimising thermal and 
optical auto–oxidation. These gel samples were probed every day for 7 days using the flatbed 
scanner to determine the gel stability.  
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4.1.7. Diffusion measurements 
To perform diffusion measurements, half of each gel container was irradiated with 30 Gy 
while the other half was shielded by shutting the lower jaw to the central axis and placing a 3 
cm lead block 1 mm over the light field edge; minimising the half field penumbra.
[77]
 To 
ensure a complete diffusion profile could be contained in a single optical CT slice of the jar, 
the half field was delivered along the vertical axis of the jar. Read–out of the half–field 
irradiated gels was performed with an MGS Research IQScan Optical CT Scanner fitted with 
a 1 mW Green Helium–Neon laser (543nm) and operating with a pixel size of 0.5 mm. Using 
an empty-tank pre–scan for each gel obtained 2 hours prior to irradiation, 9 OD slices were 
reconstructed from 1 – 50 hours after irradiation in order to determine the diffusion 
coefficient. The O.D. slices were corrected for the effects of auto-oxidation relative to the 1 
hour post-irradiation measurement. 
 
4.2. Results and Discussion 
4.2.1. Reaction rate 
Figure 4.3 shows the OD of XO-PVA as a function of time after irradiation to 20 Gy. Beyond 
the initial development period, the XO-PVA gel shows an increase in OD with time at an 
average rate of 0.015 h
-1
; a factor of ten times higher than the 0.0015 h
-1
 obtained by Chu et 
al. for the PVA-FX gel. The increase in OD with time during this measurement is primarily 
caused by auto-oxidation at room temperature and as demonstrated by Chu et al. is 
independent of dose. As seen in figure 4.5, by storing XO-PVA gel samples at 2 °C, there is a 
30 fold increase in the stability of the gels (0.00050 h
-1
 auto oxidation rate). Based on this 
measurement, the gel is sufficiently developed for post-irradiation read-out after 
approximately 30 mins. 
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Figure 4.3: OD of XO-PVA as a function of time after irradiation to 20 Gy. Note that for this 
measurement, the gel was stored at room temperature between scans. 
 
4.2.2. Dose sensitivity 
The optical dose response of the XO-PVA gel is displayed in figure 4.4(inset) up to 150 Gy. 
A linear response as a function of dose is demonstrated by the gel up to 30 Gy (linearity 
quality, r
2
, in this range is calculated as 0.9978). Additionally, the gel reaches a saturation 
point at approximately 60 Gy, similar to many other ferrous sulphate xylenol orange 
dosimeters.
[4]
 The uncertainties displayed in figure 4.4 were calculated by propagating 
standard deviations of pre– and post–scan pixel values (from the scanner images) through OD 
calculations.  
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Figure 4.4: The response in OD of the XO–PVA and PVA–FX gels in cuvettes to various 
levels of dose. The slopes were determined by least-squares linear regression. The plotted 
symbols indicate the uncertainty in the data points. Inset: The optical dose response of the 
XO-PVA gel until saturation is reached.  
 
Given that the linear range of the XO-PVA gel is approximately from 0 to 30 Gy, a 
comparison to FX-PVA in this range is useful. Figure 4.4 shows the optical response of both 
gels in the common linear range from 0 to 30 Gy. OD sensitivities and linearity quality (r
2
) 
for 0 to 30 Gy are summarised in table 4.1 along with the optical attenuation coefficient for 
each gel (calculating from their respective OD sensitivities). 
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 OD sensitivity  
(Gy
-1
) 
Linearity  
(r
2
) 
Optical attenuation coefficient 
(cm
-1 
Gy
-1
) 
XO–PVA 0.014 0.9978 0.032 
PVA–FX 0.020 0.9983 0.046 
Table 4.1: The OD sensitivity, optical attenuation coefficient, and respective linearity quality 
for the XO–PVA and PVA–FX gels. 
 
The dose sensitivity measured with the film scanner in this study for PVA–FX gel (0.020  
Gy
-1
) is substantially lower than what is measured by Chu et al. for the same gel formulation 
using a 543 nm laser and photodiode arrangement (0.046 Gy
-1
).
[69]
 It may be noted that Chu’s 
measurements were obtained with a laser wavelength of 543nm; however when measuring 
OD with the green channel of the flatbed scanner, there is a range of wavelengths centred at 
approximately 532nm. At this lower central wavelength, the absorbance difference between 
XO and Ferric-XO is smaller and thus the measured OD sensitivity is lower.
[78]
 Nevertheless, 
this doesn’t limit the scanner’s utility in determining the linearity of the XO–PVA gel’s dose 
response or in providing a relative comparison of its sensitivity to the FX–PVA gel. 
 
The measurements in this work showed a 30% reduction in the dose response of the XO–
PVA gel compared to the FX-PVA gel, with an OD dose sensitivity of 0.014 Gy
-1
 and a 
corresponding optical attenuation coefficient of 0.032 cm
-1
 Gy
-1
. Additionally, the dynamic 
OD range measured in the linear response region is reduced by 30% from 0.604 for the FX-
PVA gel to 0.415 for the XO-PVA gel. The loss in sensitivity and dynamic range present for 
the XO–PVA gel could be attributed to a lower total xylenol orange concentration in the final 
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gel mixture; a consequence of the low degree of PVA functionalisation, whereby any excess 
xylenol orange was washed off. 
 
Formation of gel using XO–PVA had a high presence of macroscopic suspended particles (an 
image highlighting this is included in figure 4.2). In figure 4.4, this effect is manifest in two 
ways: (i) greater uncertainty in OD values stemming from more noise in the XO–PVA gel’s 
OD profiles (ii) the initial OD of the XO–PVA is almost three times that of the original 
PVA–FX gel. This increased OD has negative implications on the prospect of using the XO–
PVA for larger phantoms as the longer path length will result in extinction of a probing laser 
and limit the detection dynamic range.
[79]
 Despite this, both gels clearly demonstrate a linear 
dose response. 
 
4.2.3. Auto–oxidation rates 
Figure 4.5 shows OD measurements of the non-irradiated gels are plotted against time. 
Uncertainties in the OD values were calculated using the same method as outlined for dose 
response measurements. The auto–oxidation rate (h-1) is taken as the slope of the plot in 
figure 4.5. 
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Figure 4.5: The increase in OD of non-irradiated gels as a function of time due to auto–
oxidation. The plotted symbols indicate the uncertainty in the data points. 
 
The OD of unirradiated XO–PVA gel increased by a rate (0.00050 h-1) ten times greater than 
the PVA–FX gel (0.00005 h-1). The difference between these two values may be attributed to 
phase separation of the polymers as the production of XO-PVA produces distinct 
hydrophilic/hydrophobic groups that may form microdomains. Regardless, these 
measurements of stability indicate that samples of either gel, which are kept refrigerated, can 
still be used days or potentially weeks after the gel has been mixed. This is definitely 
advantageous, however it must be noted that the increase in background OD when waiting 
longer than a few weeks can result in probing laser extinction in large phantoms and reduce 
the detection dynamic range. 
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4.2.4. Diffusion rates 
To quantify diffusion rates, the standard method outlined by Kron et al. was employed.
[70]
  
Step–shaped OD profiles were collected from the Optical CT slices using ImageJ (figure 4.6). 
These diffusion profiles were fit to equation (4.1): 
𝑌 = 𝑌0 +
1
2
(𝑌1 − 𝑌0) [1 +
(𝑋 − 𝑋0)
√(𝑋 − 𝑋0)2 + 𝑛
]                                          (4.1) 
Where Y is the measured OD at the position X, X0 is the horizontal shift of the inflection 
point, Y0 and Y1 are the minimum and maximum values of Y, and n is the curvature 
parameter that characterizes the slope of the inflection point. 
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Figure 4.6: Typical OD line profiles taken 1, 3, 6, 23 and 50 hours post-irradiation from the: 
A PVA-FX gel and B XO–PVA gel. Part C shows a scaled comparison of the diffusion curves 
for both gels at 1 and 6 hours.  
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As demonstrated by Kron et al. a plot of n versus time after irradiation is linear (figure 4.7) 
and when the factor 0.212 is multiplied by its slope, the diffusion coefficient, D (mm
2
 h
-1
) is 
obtained. 
Figure 4.7: Plots of the curvature parameter ‘n’ as a function of time for the XO–PVA and 
PVA–FX gels. The plotted symbols indicate the uncertainty in the data points. 
The diffusion coefficient, measured for the PVA–FX hydrogel matched results reported by 
Chu et al., with a value of 0.141 ± 0.002 mm
2
 h
-1
.
[69]
 The XO–PVA formulation yielded a 
diffusion rate of 0.129 ± 0.004 mm
2
 h
-1
. This is an 8% improvement on the existing PVA–FX 
gel and is considerably lower than all previously published values ranging from 0.3 to 2.2 
mm
2
 h
-1
.
[70]
 It may be noted here that due to the difficulty associated with a using a 20% PVA 
gel, it would be easier to use 10% or 15% PVA, however this would result in a higher 
diffusion rate and lessen the improvement made from the XO-PVA.  
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The mechanism governing the decreased diffusion rate in XO–PVA gel is the bonding of 
xylenol orange to PVA. The investigated functionalization method has no impact on the 
xylenol orange molecules chelation ability as the functionalization site isn’t located near the 
carboxylic acid groups responsible for ferric ion trapping. Ferric xylenol orange molecules 
bound to the PVA gel matrix are unable to diffuse. However, since the technique used to 
synthesise the XO–PVA did not result in high degrees of reporter molecule integration 
(compare with Fan et al. which reported bonding of XO on silica gel was 18.26 𝜇mol), there 
is inevitably a portion of xylenol orange molecules in the final gel mixture that aren’t bound 
to the PVA matrix. Therefore part of the remaining diffusion in this gel can be attributed to 
the fraction of xylenol orange molecules, which did not successfully bond to PVA during the 
preparation of XO–PVA. To further improve this result, more efficient methods of bonding 
xylenol orange to PVA must be explored. 
 
4.2.5. Manufacturing Considerations 
The amount of XO-PVA yielded from the method outlined is typically less than 10 grams. 
The author notes that when attempting to wash unbound xylenol orange off the final XO-
PVA compound, large PVA molecular clusters can form (with diameters up to approximately 
1.5 cm) due to PVA’s strong tendency to aggregate when coming out of solution. Within 
these large clusters, unbonded xylenol orange molecules become trapped, which cannot be 
removed by simply washing with solvent. To minimise this, a successive 
dissolution/precipitation protocol is followed several times, however given the properties of 
PVA, there is residual XO present that isn't effectively bonded to the polymer. Because of 
this, analytic techniques such as spectroscopic measurements of the eluate and final gel do 
not give an accurate indication of the bound/unbound xylenol orange presence in XO-PVA. 
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The same issues do not apply when using silica gel as Fan et al. did;
[76]
 silica gel precipitates 
as small particles that do not have the retention effect that the clusters of PVA do. Therefore 
when functionalising the silica gel, the washing process can effectively remove all unbound 
XO and their spectroscopic measurements provide an accurate indication of the amount of 
bound silica gel. 
 
4.3. Conclusions 
This chapter investigated the use of a functionalised polymer to reduce the rate of Fe
3+
 
diffusion in the PVA Fricke hydrogel. Preparing gels using the investigated method of 
functionalizing PVA with xylenol orange yields a dosimeter with a linear OD dose response 
from 0 to 30 Gy (r
2
 = 0.9978) with a sensitivity of 0.014 Gy
-1
, an auto oxidation rate of 
0.0005 h
-1
 and a diffusion coefficient of 0.129 mm
2
 h
-1
 measured via optical CT. Compared to 
the PVA Fricke hydrogel with the same PVA and Ferrous ion concentrations, the XO-PVA 
gel suffers a clear reduction in dose sensitivity and dynamic range over the linear dose 
response region along with an increased auto oxidation rate. The functionalization method 
explored here has produced an 8% reduction in diffusion rate, indicating only a low degree of 
xylenol orange integration. Given the added difficulty in manufacturing the gel presented in 
this chapter, the improvement in diffusion is not great enough to provide a significant 
practical benefit. As such, more efficient functionalization methods must be developed for 
this system to gain clinical relevance.   
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Chapter 5 
 
Total synthesis of xylenol orange – substituted PVA 
 
 
The work described in chapter 4 resulted in partial functionalisation of PVA with xylenol 
orange and a definite, but limited reduction in diffusion. The next step in the work was to 
pursue a lengthier (but more certain) ab initio chemical synthesis to quantitatively produce 
the target molecule. The preface of this chapter describes the approach to the synthesis with 
Schemes 5.1 and 5.2 providing a visual representation of all novel steps in the synthesis. 
Following this, Section 5.1 details the specific methods employed at every step of the 
synthesis to xylenol orange – substituted PVA. For each synthesis step, full characterisation 
data is listed including 
1
H NMR, 
13
C NMR, HR-MS, and FTIR where applicable. The work 
presented in this chapter is in preparation for submission to Reactive and Functional 
Polymers. 
 
For the synthesis in this chapter, the Huisgen 1, 3-Dipolar Cycloaddition of alkynes and 
azides was used – aka the ‘Click’ reaction. ‘Click’ chemistry is a term used to describe a set 
of reactions which are reliable, high yielding, simple to perform, and create by-products 
which only require simple filtration to be removed. Click reactions have found successful use 
in various polymer functionalisations where simple and reliable procedures are required to 
eliminate the complications of polymer purification. With such properties, it is an ideal 
candidate for bonding the sensitive xylenol orange molecule to PVA.  
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Although this final linking step is relatively simple, the preceding preparation of azide-
functionalised PVA and alkyne-xylenol orange incurs more challenging, less well-
precedented chemistry. Compounds 5.1 to 5.4 are obtained via established literature 
methods
[80, 81]
 and as such their synthesis is not shown in the reaction scheme. Scheme 5.1 
shows the developed synthesis route to Alkyne-xylenol orange via modified literature 
procedures.
[82] 
Compound 5.5 is produced by the Mannich condensation of 5.4 and o-
cresol.
[80]
 A Pd/Cu(I)-catalysed Sonogashira coupling of 5.5 with (trimethylsilyl)acetylene 
yields compound 5.6. Subsequently, a TMS deprotection obtains Compound 5.7. 
Functionalising the compound with the alkyne group at this point in the synthesis ensures no 
interaction of coupling reagents with the free-acid groups present in the final xylenol orange 
molecule. Alkyne-xylenol orange 5.8 is then obtained by reacting 5.7 with iminodiacetic acid 
and formaldehyde.  
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SCHEME 5.1. Preparation of alkyne-xylenol orange (methods detailed in sections 5.1.2. 
to 5.1.9.) 
 
 
2-azidoethylamine-substituted PVA 5.9 is synthesised similarly to published methods
[83]
 and 
reacted with 5.8 in the presence of the Cu(I)
+
 catalyst yielding the titular compound 5.10 as 
shown in Scheme 5.2. Notably in this step, some excess copper remains bound to 5.10, even 
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after purification by dialysis against EDTA. This is an unavoidable outcome of strong 
chelation by xylenol orange and results in significant peak broadening in NMR spectra. 
Regardless, the success of the reaction is evident in the removal of azide peak in FTIR 
spectra and the addition of triazole proton in 
1
H NMR. 
SCHEME 5.2. Preparation of xylenol orange-substituted PVA (methods detailed in 
sections 5.1.10. to 5.1.11.) 
 
 
5.1. Experimental Section 
5.1.1. General 
2-Azidoethylamine
[84]
 was prepared according to literature procedures. All other reagents 
were purchased from Sigma Aldrich (Sydney) and used as received. Poly(vinyl alcohol) 
(PVA) was purchased with average molecular weight 13000 - 23000 g/mol (degree of 
acetylation 98.0 - 98.8 %). All solvents were of analytical quality. Dialysis membrane 
(Spectra/Por 1) was selected with MW cut-off of 6000 – 8000 g/mol. 1H NMR experiments 
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were performed on a Varian direct drive spectrometer (AutoX probe), operating at 400 MHz. 
13
C NMR experiments were performed on a Bruker 600 Advance III D (ATX probe), 
operating at 600 MHz. Fourier transform infrared (FTIR) spectra were recorded using a 
Nicolet Diamond ATR 5700.  
 
5.1.2. 4-Nitro-2-sulfobenzoic acid (5.1). 
A slurry of KMnO4 (150 g, 950 mmols, 3.96 equiv.) in 1.2 L H2O was prepared in a flask. 4-
nitrotoluene-2-sulfonic acid (51.5 g, 240 mmols, 1 equiv.) was dissolved in 300 mL H2O and 
added to the flask. A water-cooled condenser was attached and the system was stirred at 
reflux overnight. The reaction was cooled on ice and filtered to give a tan solution. The solid 
was washed with ~2 L H2O, and the filtrate was subsequently concentrated under vacuum to 
give approximately 1 L. The mixture was cooled on ice and acidified with concentrated HCl 
until the pH was less than 1. The mixture was heated to dissolve the white precipitate, and 
cooled slowly to form crystals. The flask was sealed and stored overnight at 4 °C, the off-
white crystals were filtered, washed with ~50 mL of cold HCl solution (pH – 1) and dried on 
a Buchner funnel to give 42.2 g (72%) of 4-nitro-2-sulfobenzoic acid as an off-white solid. 
Purity 89% by 
1
H NMR. 
1
H NMR: δ (DMSO-d6): 8.47 (1H, d, J = 2.4 Hz); 8.24 (1H, dd, J1 = 
8.4 Hz, J2 = 2.4 Hz); 7.70 (1H, d, J = 8.0Hz). 
 
1
H NMR Characterisation 
 
 
 
 Literature compound[81] 
  
Proton Chemical Shift 
(ppm) 
Multiplicity Coupling constant 
(Hz) 
1 8.47 d J=2.4 
2 8.24 dd J1=8.4, J2=2.4 
3 7.70 d J=8.0 
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5.1.3. 4-Amino-2-sulfobenzoic acid (5.2). 
Compound 5.1 (42.2 g, 173.3 mmols, 1 equiv.) was dissolved in 125 mL of H2O and stirred 
in a flask fitted with a reflux condenser. The reaction was heated to boiling and the mixture 
became homogenous. 26.7 mL of acetic acid was added followed by Fe (48.7 g, 866.5 
mmols, 5 equiv.) in 5 g portions every 10 mins to avoid excess bubbling and ensure mobility 
of the magnetic stirring bar. Once the addition was complete, the reaction was refluxed for 
one additional hour. The reaction mixture was then transferred to an Erlenmeyer flask, heated 
to boiling, and filtered while hot to remove unreacted iron. The solid was washed with 
several portions of boiling water (approximately 500 mL total), yielding a pale green filtrate. 
This solution was again heated to boiling and filtered through a thin pad of celite® to get a 
pale orange solution. The filtrate was concentrated in vacuo, cooled on ice, and acidified with 
concentrated HCl until the pH was less than 1 and a yellow precipitate formed. The mixture 
was heated to dissolve the precipitate, and cooled slowly. The flask was sealed and stored 
overnight at 4 °C, the beige solid was filtered to 8.7 g (24%) of 4-amino-2-sulfobenzoic acid, 
pure by 
1
H NMR. 
1
H NMR: δ (DMSO-d6): 7.63 (1H, d, J = 8.4 Hz); 7.18 (1H, d, J = 2.0 Hz); 
6.65 (1H, d, J = 8.4Hz). 
 
1
H NMR Characterisation 
 
 
 
Literature compound[81] 
 
  
Proton Chemical Shift 
(ppm) 
Multiplicity Coupling constant 
(Hz) 
1 7.63 d J=8.4 
2 7.18 d J=2.0 
3 6.65 d J=8.4 
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5.1.4. 4-Iodo-2-sulfobenzoic acid (5.3). 
Compound 5.2 (8.7 g, 40.2 mmols, 1 equiv.) was suspended in 80 mL water. Na2CO3 was 
added until the pH was 8 (approximately 5 g) and stirring was continued until the solution 
was homogenous. This was cooled on ice, before NaNO2 (3.08 g, 45.0 mmols, 1.12 equiv.) 
dissolved in 8 mL water was added. After cooling on ice again, HCl (8.7 mL concentrated 
HCl diluted in 40 g crushed ice) was added (so the pH~3) and stirring was continued on ice 
for 30 minutes. A solution of NaI (7.26 g, 48.2 mmols, 1.2 equiv.) in 8 mL H2O was added 
dropwise, the reaction produced gas and went dark. Stirring was maintained for 2 hours on 
ice, then 1 hour at room temperature and finally at 50 °C overnight. The following morning, 
concentrated HCl was added dropwise until the pH was less than 1. The reaction was 
concentrated in vacuo to give a red/orange solid. This was recrystallized from boiling H2O. 
The fluffy orange crystals were filtered and washed with ~10 mL of cold HCl solution (pH-1) 
to get 6.53 g of 4-iodo-2-sulfobenzoic acid. The mother liquid was concentrated to dryness 
and recrystallized again to get an additional 1.07 g (58% yield, total). 
1
H NMR: δ (DMSO-
d6): 8.07 (1H, d, J = 1.6 Hz); 7.83 (1H, dd, J1 = 8.4 Hz, J2 = 1.6 Hz); 7.38 (1H, d, J = 8.0Hz). 
 
1
H NMR Characterisation 
 
 
 
Literature compound[81] 
 
  
Proton Chemical Shift 
(ppm) 
Multiplicity Coupling constant 
(Hz) 
1 8.07 d J=1.6 
2 7.83 dd J1=8.4, J2=1.6 
3 7.38 d J=8.0 
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5.1.5. 4-Iodo-2-sulfobenzoic anhydride (5.4). 
Compound 5.3 (7.6 g, 21.7 mmols, 1 equiv.) was placed in a flask fitted with a water cooled 
reflux condenser. Thionyl chloride (15.8 mL, 217 mmols, 10 equiv.) was added and the 
mixture was refluxed under Argon overnight. After cooling to room temperature, thionyl 
chloride was removed in vacuo. Then toluene (60 mL) was added and stirred while boiling 
for one hour. The hot mixture was filtered and washed with ~100 mL of hot toluene. The 
filtrate was dried in vacuo to give 1.74 g of 4-iodo-2-sulfobenzoic anhydride as on off-white 
solid (26% yield). 
1
H NMR: δ (CDCl3): 8.34 (1H, s); 8.29 (1H, d, J = 8.0 Hz); 7.84 (1H, dd, 
J1 = 8.2 Hz, J2 = 0.6 Hz). 
 
1
H NMR Characterisation 
 
 
 
Literature compound[80]   
Proton Chemical Shift 
(ppm) 
Multiplicity Coupling constant 
(Hz) 
1 8.34 s  
2 8.29 d J=8.0 
3 7.84 dd J1=8.2, J2=0.6 
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5.1.6. 3,3-Bis(4-hydroxy-3-methylphenyl)-5-iodo-3H-benzo[c][1,2]oxathiole 1,1-dioxide 
(5.5). 
Compound 5.4 (1.74 g, 5.60 mmols, 1 equiv.) and o-cresol (1.21 g, 11.2 mmols, 2 equiv.) 
were weighed into a flask. Methanesulfonic acid (11 mL) was added and the mixture was 
heated at 90 °C under Argon overnight. After cooling to room temperature, the red solution 
was added to a flask of water (70 mL) and filtered. The solid was dissolved in NaOH (35 mL 
of a 10% v/v solution) and filtered. The filtrate was carefully acidified with concentrated HCl 
until the pH reached 2. A red solid formed which was collected by filtration and dried in 
vacuo to give 2.25 g (79% yield). 
1
H NMR: δ (DMSO-d6): 8.17 (1H, s); 7.71 (1H, d, J = 8.4 
Hz); 7.01 (4H, m); 6.75 (1H, d, J = 8.0 Hz); 6.49 (2H, d, J = 9.2 Hz); 1.93 (6H, s). 
13
C NMR: 
δ (DMSO-d6): 146.46, 138.01, 137.74, 135.95, 135.56, 135.20, 132.42, 129.54, 128.21, 
119.62, 95.18, 16.60. HRMS (ESI-TOF) m/z (M-H)
-
 calculated for C21H16O5IS 506.9763, 
found 506.9765. 
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1
H NMR Characterisation 
 
 
 
 
 
 
 
 
 
 
13
C NMR Characterisation 
 
 
 
 
 
 
 
 
 
 
 
 
  
Proton Chemical Shift 
(ppm) 
Multiplicity Coupling constant 
(Hz) 
1 8.17 s  
2 7.71 d J=8.4 
3 6.75 d J=8.0 
4 (2H) 6.49 d J=9.2 
5 (2H) 7.01 m  
6 (2H) 7.01 m  
7 (6H) 1.93 s  
Carbon Chemical Shift 
(ppm) 
1 (2C) 16.60 
2 (2C) 119.62 
3 (2C) 135.56 
4 135.95 
5 95.18 
6 95.18 
7 (2C) 129.54 
8 128.21 
9 (2C) 132.42 
10 (2C) 138.01 
11 146.46 
12 137.74 
13 135.20 
14 (2C) 129.54 
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5.1.7. 3,3-Bis(4-hydroxy-3-methylphenyl)-5-((trimethylsilyl)ethynyl)-3H-
benzo[c][1,2]oxathiole 1,1-dioxide (5.6). 
Compound 5.5 (1 g, 1.97 mmols, 1 equiv.), Pd(PPH3)2Cl2 (50.7 mg, 0.078 mmols, 0.04 
equiv.), and Cu(I) (7.2 mg, 0.038 mmols, 0.02 equiv.) were weighed into a flask and stirred 
under argon in dry THF (20 mL) until mostly dissolved. Triethylamine (0.55 mL, 3.94 
mmols, 2 equiv.) was added and the solution turned dark and produced gas. 
(Trimethylsilyl)Acetylene (0.55 mL, 3.94 mmols, 2 equiv.) was added and the reaction was 
stirred overnight at 60 °C under Argon. The flask was cooled to R.T., the solids were filtered 
off and the mixture was dried in vacuo. The crude product was purified by silica gel 
chromatography using EtOAc/MeOH (v/v 85:15) as eluent. The product was obtained as a 
red solid. Yield: 620.3 mg (65.9%). 
1
H NMR: δ (D2O): 7.81 (1H, s); 7.09 (1H, d, J = 7.6 
Hz); 6.81 (4H, m); 6.61 (1H, d, J = 8.0 Hz); 6.36 (2H, d, J = 4.0 Hz); 1.73 (6H, s); 0.16 (9H, 
s). 
13
C NMR: δ (DMSO-d6): 166.46, 141.56, 138.60, 134.29, 133.21, 132.57, 129.12, 128.88, 
126.68, 122.66, 117.63, 103.42, 96.22, 59.53, 15.80, 0.50. HRMS (ESI-TOF) m/z (M-H)
-
 
calculated for C26H25O5SSi 477.1192, found 477.1195. 
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1
H NMR Characterisation 
 
 
 
 
13
C NMR Characterisation 
 
 
 
 
 
 
 
 
 
 
  
Proton Chemical Shift 
(ppm) 
Multiplicity Coupling constant 
(Hz) 
1 7.81 s  
2 7.09 d J=7.6 
3 6.61 d J=8.0 
4 (2H) 6.36 d J=4.0 
5 (2H) 6.81 m  
6 (2H) 6.81 m  
7 (6H) 1.73 s  
8 (2H) 1.87 s  
9 (9H) 0.16 s  
Carbon Chemical Shift 
(ppm) 
1 (3C) 0.50 
2 (2C) 15.80 
3 (2C) 134.29 
4 103.42 
5 96.22 
6 (2C) 129.12 
7 (2C) 117.63 
8 (2C) 133.21 
9 (2C) 166.46 
10 122.66 
11 132.57 
12 138.60 
13 141.56 
14 (2C) 126.68 
15 128.88 
16 129.43 
17 59.53 
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5.1.8. 5-Ethynyl-3,3-bis(4-hydroxy-3-methylphenyl)-3H-benzo[c][1,2]oxathiole 1,1-
dioxide (5.7). 
Compound 5.6 (620 mg, 1.3 mmols, 1 equiv.) and anhydrous KCO3 (269 mg, 1.95 mmols, 
1.5 equiv.) were weighed into a flask and stirred in MeOH (15 mL) overnight. The solution 
turned deep purple. The mixture was dried in vacuo before 20 mL of EtOAc:MeOH (v/v 
85:15) was added. This was carefully neutralised with concentrated HCl such that the 
solution turned orange/yellow and the product dissolved. The mixture was filtered through a 
thin pad of celite® and dried in vacuo yielding compound 5.7 as a red/orange solid. Yield: 
526.5 mg (100%). 
1
H NMR: δ (D2O): 7.93 (1H, s); 7.50 (1H, d, J = 8.0 Hz); 7.01 (5H, m); 
6.48 (2H, d, J = 8.8 Hz); 3.45 (1H, s); 1.84 (6H, s). 
13
C NMR: δ (D2O): 162.24, 142.40, 
137.78, 137.30, 136.96, 134.84, 133.27, 131.39, 129.64, 126.40, 123.08, 120.38, 82.01, 
80.79, 15.62. HRMS (ESI-TOF) m/z (M-H)
-
 calculated for C23H17O5S 405.0797, found 
405.0798. 
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1
H NMR Characterisation 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
13
C NMR Characterisation 
 
 
 
 
 
 
 
 
 
 
  
Proton Chemical Shift 
(ppm) 
Multiplicity Coupling constant 
(Hz) 
1 7.93 s  
2 7.50 d J=8.0 
3 7.01 m  
4 (2H) 6.48 d J=8.8 
5 (2H) 7.01 m  
6 (2H) 7.01 m  
7 (6H) 1.84 s  
8 3.45 s  
Carbon Chemical Shift 
(ppm) 
1 (2C) 15.62 
2 80.79 
3 82.01 
4 (2C) 120.38 
5 123.08 
6 (2C) 137.30 
7 (2C) 136.96 
8 (2C) 129.64 
9 (2C) 131.39 
10 142.40 
11 133.27 
12 133.27 
13 126.40 
14 134.84 
15 137.78 
16 (2C) 162.24 
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5.1.9. Alkyne-xylenol orange (5.8). 
Compound 5.7 (527 mg, 1.3 mmols, 1 equiv.), iminodiacetic acid (690 mg, 5.19 mmols, 4 
equiv.), sodium acetate (1.32 g), and formaldehyde (37% Aqueous, 0.61 mL, 7.8 mmols, 6 
equiv.) were mixed with 13 mL of glacial acetic acid overnight at 65 °C. All components 
were completely dissolved by the next morning. Approximately half the volume was 
removed under reduced pressure, the residue was cooled down and precipitated by adding 20 
mL EtOH. The precipitate was captured by filtration, washed with EtOH (2 × 20 mL) and 
Ether (2 × 20 mL) then air dried. The solid was dissolved in 3 mL of H2O, where after 1 mL 
of saturated sodium acetate solution and 100 mL of EtOH was added. After standing for 2 
hours, the red liquid was decanted and the residue is mixed with a surplus of EtOH. After 
standing overnight, the dark solid was captured with a pad of celite®, washed with EtOH, 
flushed through with MeOH and dried yielding 874.6 mg (97%). 
1
H NMR: δ (D2O): 7.94 
(1H, s); 7.54 (1H, d, J = 8.4 Hz); 7.02 (5H, m); 4.02 (4H, s); 3.46 (8H, s); 3.43 (1H, s); 1.83 
(6H, s); 1.68 (2H, s). 
13
C NMR: δ (D2O): 171.45, 142.71, 140.38, 138.91, 138.18, 133.80, 
132.60, 131.17, 130.89, 125.40, 123.41, 121.53, 81.90, 80.57, 57.01, 56.37, 15.83. HRMS 
(ESI-TOF) m/z (M-2H)
2-
 calculated for C33H30O13N2S 347.0734, found 347.0739. 
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1
H NMR Characterisation 
 
 
 
 
 
 
 
 
 
 
 
 
 
13
C NMR Characterisation 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Proton Chemical Shift 
(ppm) 
Multiplicity Coupling constant 
(Hz) 
1 7.94 s  
2 7.54 d J=8.4 
3 7.02 m  
4 (4H) 4.02 s  
5 (2H) 7.02 m  
6 (2H) 7.02 m  
7 (6H) 1.83 s  
8 (2H) 1.68 s  
9 3.43 s  
10 (8H) 3.46 s  
Carbon Chemical Shift 
(ppm) 
1 (2C) 15.83 
2 (4C) 57.01 
3 (2C) 56.37 
4 80.59 
5 81.89 
6 (2C) 130.89 
7 (2C) 131.17 
8 133.80 
9 (2C) 132.60 
10 (2C) 125.40 
11 (2C) 138.91 
12 (2C) 140.38 
13 123.41 
14 138.18 
15 138.92 
16 140.38 
17 142.71 
18 121.53 
19 171.44 
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5.1.10. 2-Azidoethylamine-substituted PVA (5.9). 
PVA (4g, 90 mmols of hydroxyl groups, 1 equiv.) was weighed into an oven dried flask, and 
purged with Argon. 80 mL of dry DMSO was added and the flask was heated and stirred until 
all PVA was dissolved. 1,1’-Carbonyldiimidazole (7.304 g, 45 mmols, 0.5 equiv.) was added 
all in one portion and stirring was continued for 45 minutes under Argon at room 
temperature. 2-Azidoethylamine (1.161 g, 13.5 mmols, 0.15 equiv.) was dissolved in 8 mL 
dry DMSO and added to the reaction. Stirring was continued overnight at room temperature 
under Argon. Afterwards, 40 mL of concentrated aqueous NH3 was added and the mixture 
was stirred for 1 hour at room temperature. 400 mL of H2O was added to dilute the mixture 
and it was filtered until clear. The volume was reduced to approximately 90 mL under 
reduced pressure.  The polymer was precipitated from the residual DMSO by dropwise 
addition to a vigorously stirred solution of EtOH (1 L). Remaining impurities were removed 
by a successive dissolution-precipitation protocol. The polymer was freeze dried giving a 
white solid. Yield: 4.27 g (95%), DS: 0.032. 
1
H NMR: δ (D2O): 4.77 ((DS × 1)H, m, 
partially overlapped with H2O signal); 4.00-3.50 (1H, m); 3.20-3.10 ((DS × 4)H, 2×m); 2.00-
1.20 (4H, m). 
13
C NMR: δ (D2O): 159.22, 70.25, 68.05-64.05, 50.57, 44.80-44.00. FTIR – 
N=N=N stretch band – 2100 cm-1.  
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1
H NMR Characterisation 
 
 
 
 
 
Literature compound[74] 
 
13
C NMR characterisation 
 
 
 
 
 
 
FTIR 
N=N=N stretch band – 2100 cm-1 
  
Proton Chemical Shift 
(ppm) 
Multiplicity 
1 ((DS×1)H 4.77 m 
2 (4H) 2.00-1.20 m 
3 4.00-3.50 m 
4 ((DS×2)H) 3.20-3.10 m 
5 ((DS×2)H) 3.20-3.10 m 
Carbon Chemical Shift 
(ppm) 
1 (2C) 44.80-44.00 
2 68.05-64.05 
3 ((DS×1)H) 70.25 
4 ((DS×1)H) 159.22 
5 ((DS×1)H) 50.57 
6 ((DS×1)H) 50.57 
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5.1.11. Xylenol orange-substituted PVA (5.10). 
2-Azidoethylamine-substituted PVA (645 mg, 0.43 mmols of substituted groups, 0.33 equiv.) 
was dissolved in 8 mL H2O. Alkyne-xylenol orange (904 mg, 1.30 mmols, 1 equiv.) was 
dissolved in 8 mL H2O and added. Sodium ascorbate (1.54 g, 7.79 mmols, 6 equiv.) followed 
by copper (II) sulphate pentahydrate (389 mg, 1.56 mmols, 1.2 equiv.) were then dissolved in 
H2O and added. The mixture was stirred overnight. Subsequently, the reaction mixture was 
dialyzed against EDTA in water for 24 hours, then against water for another 48 hours, 
changing and screening the filtrate every 12 hours until the filtrate showed no sign of 
unbound xylenol orange by 
1
H NMR. The dialyzed solution was subsequently freeze dried 
yielding a flaky purple solid 837 mg (88% yield). 
1
H NMR: δ (D2O): 8.21 ((DS × 1)H, 
broadened signal); 7.90-6.20 ((DS×1)H, broadened m); 4.00-3.40 (1H, broadened signal); 
3.20-3.00 ((DS × 4)H, broadened signal); 2.00-0.70 (4H, broadened signal). 
13
C NMR: δ 
(D2O): 68.44-63.93, 45.08-40.45, remaining signals unresolvable due to low signal to noise 
even with saturated NMR sample. FTIR – Removal of N=N=N stretch band – 2100 cm-1. 
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1
H NMR Characterisation 
 
 
 
 
 
 
 
13
C NMR Characterisation 
 
 
 
 
 
 
 
 
FTIR 
Removal of N=N=N stretch band – 2100 cm-1  
 
Proton Chemical Shift 
(ppm) 
Multiplicity 
1 ((DS×1)H Under H2O 
2 (4H) 2.00-0.70 Broad s 
3 4.00-3.40 Broad s 
4 ((DS×2)H) 3.20-3.00 Broad s 
5 ((DS×2)H) 3.20-3.00 Broad s 
6 ((DS×1)H 8.21 Broad s 
R – Xylenol 
Orange 
7.90-6.20 Broad m 
Carbon Chemical Shift 
(ppm) 
1 (2C) 45.08-40.45 
2 68.44-63.93 
3 ((DS×1)H) 
Signal to Noise 
is too low to 
determine 13C 
shifts, even with 
a saturated 
solution of the 
analyte. 
4 ((DS×1)H) 
5 ((DS×1)H) 
6 ((DS×1)H) 
7 ((DS×1)H) 
8 ((DS×1)H) 
R – Xylenol 
Orange 
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5.2. Conclusions 
The synthesis presented in this chapter, provides a means of covalently bonding xylenol 
orange to PVA which involves minimal chromatography and high yields for most steps. 
Modifications to published synthesis methods were applied to obtain alkyne-xylenol orange 
5.8 (Scheme 5.1). An azide-functionalised PVA 5.9 was produced and reacted with 5.8 
through the Cu(I) catalysed Huisgen [3 + 2] cycloaddition defined as a ‘click’ reaction 
(Scheme 5.2). All compounds throughout the synthesis have been confirmed via NMR along 
with HR-MS and/or FTIR analysis. Purification of the final compound by dialysis confirmed 
that no unbound xylenol orange remains in the product and thus the compound is ready to be 
integrated into a gel dosimetry system.  
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Chapter 6 
 
Characterisation of xylenol orange substituted –
PVA based gel dosimeter 
 
 
With the production of xylenol orange substituted –PVA in Chapter 5, the final investigation 
of this work was to incorporate this molecule into a Fricke gel dosimeter. Here, unlike the 
measurements in Chapter 4, a number of gel formulations were investigated to determine the 
optimal gelling agent, the optimal ferrous sulphate/xylenol orange concentration, and the 
effects of glyoxal, an additive which has been shown to have positive impacts on dosimetric 
properties of Fricke gels.
[71, 75]
 This optimized gel then had a number of extra characterisation 
measurements performed on it to further highlight its viability as a dosimeter. The results 
presented here in Chapter 6 represent the final product of this research and is in preparation 
for submission to Medical Physics. 
 
6.1. Methods 
6.1.1. Xylenol Orange – Substituted PVA 
Poly(vinyl alcohol) was functionalised with xylenol orange according to the Cu(I) catalysed 
Huisgen [3+2] cycloaddition of alkyne-xylenol Orange and 2-azidoethylamine-substituted 
PVA outlined in Chapter 5. The degree of substitution (DS) based on NMR data is estimated 
to be 0.032 (i.e. 1 in 31 hydroxyl groups modified). Accordingly, the effective molecular 
weight of the polymer for each xylenol orange molecule is 2189 g/mol. 
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Figure 6.1: Xylenol orange – substituted PVA structure.[86] 
 
6.1.2. Inter-comparison of formulations 
A variety of gel dosimeter formulations incorporating xylenol orange – substituted PVA were 
investigated to optimise dose sensitivity, auto-oxidation, diffusion of dose information, and 
general practicality. Impacts of the bifunctional crosslinking agent, glyoxal were also 
investigated due to successful results in gelatin based Fricke gels from published 
investigations.
[71, 75]
 The various prepared gels are listed in table 6.1. Once an optimal 
formulation was identified, a more in depth characterisation of its dosimetric properties and 
practical use was conducted. 
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Formulation Gel 
agent 
Xylenol orange – substituted PVA 
and Fe(SO4)2 concentration 
[87]
 
Concentration 
of gel agent 
(w/v) 
Additive 
1 Gelatin 0.4 10 - 
2 Gelatin 0.4 10 Gyloxal (10mM) 
3 PVA 0.4 10 - 
4 PVA 0.4 20 - 
5 Gelatin 0.2 10 Gyloxal (10mM) 
6 Gelatin 0.1 10 Gyloxal (10mM) 
Table 6.1: Summary of gel dosimeters incorporating xylenol orange – substituted PVA. 
 
6.1.3. Gel Production 
Xylenol orange – substituted PVA (0.1 – 0.4 mM, based on effective MW of 2189 g/mol) 
was mixed in a flask of aqueous sulfuric acid (50 mM) while being stirred and heated on a 
hotplate at 55 °C. Once this was dissolved the appropriate gelling agent was added and 
dissolved. 
 For formulations 1, 2, 5, and 6, porcine gelatin (10% w/v, 300 bloom, Sigma Aldrich, 
Sydney) was added and stirred at 55 °C until dissolved. Upon dissolution, the gel 
turned dark due to an increase in the pH of the mixture. Concentrated sulfuric acid 
was added dropwise until the pH was 1 – 1.5. 
 For formulations 3 and 4, PVA (10% and 20% w/v respectively, fully hydrolysed, 
MW 89000–98000, Sigma Aldrich, Sydney) was slowly added and stirred at 95 °C, 
which took approximately 3 hours. 
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Subsequently, the temperature was reduced to approximately 40 °C and ferrous sulphate 
heptahydrate (0.1 – 0.4 mM, Sigma Aldrich, Sydney) dissolved in 50 mM sulfuric acid was 
added. Stirring was continued for 20 mins before gel formulations 1, 3, and 4 were poured 
into 1 cm plastic cuvettes. For gel formulations 2, 5, and 6, glyoxal (10 mM, 40% w/v in 
H2O, Sigma Aldrich, Sydney) was added and stirring was continued for another 10 mins 
before the mixture was poured into 1 cm plastic cuvettes. Gel cuvettes were stored at 2 °C. 
 
6.1.4. Dose response measurements 
Dose response curves were obtained by irradiating cuvettes, which were placed on top of 9 
cm Solid Water, covered at a depth of 1 cm by Bolus and Solid Water. Irradiations were 
performed using a 6 MV photon beam from a Varian EX Clinac (Varian Medical Systems, 
Palo Alto, USA) with an SSD of 100 cm and a dose rate of 600 MU/min. For comprehensive 
dose response measurements of the optimised gel, cuvettes were irradiated with 0 to 107 Gy. 
To perform comparative measurements of the various formulations, gel cuvettes were 
irradiated from 0 to 32 Gy. To maximise signal to noise ratios and scanning resolution, the 
optical densities (ODs) of the gels were measured using the green channel of an Epson 
Perfection V700 flatbed scanner (as performed in Chapter 4).
[84]
 All OD values were obtained 
through the 1 cm path length defined by the cuvette dimensions with an imaging resolution of 
600 dpi. The reference intensity for flatbed scanner measurements were found by performing 
a blank pre-scan and measuring the pixel values across the same area as the irradiated gel 
cuvette. 
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6.1.5. Auto–oxidation measurements 
One cuvette of each gel was left un–irradiated and stored at 2 °C, minimising thermal and 
optical auto–oxidation. These gel samples were probed at frequent intervals over 7 days using 
the flatbed scanner to determine the gel stability. 
 
6.1.6. Diffusion measurements 
To perform diffusion measurements, half of each gel cuvette was irradiated with 30 Gy while 
the other half was shielded by shutting the lower jaw to the central axis and placing a 5 cm 
lead block 1 mm over the light field edge; minimising the half field penumbra.
[77]
 Read–out 
of the half–field irradiated gels was performed with the flatbed scanner, obtaining diffusion 
profiles from 1 – 105 hours after irradiation. O.D. profiles of the diffusion cuvettes were 
collected with ImageJ and auto-oxidation effects were subtracted from each profile relative to 
the 1 hour post-irradiation measurement. Using least squares regression, the data was fit to an 
approximation of the complementary error function.
[70]
 Following the methods detailed by 
Kron et al., the gradient of a plot of the curvature parameter (n, mm
2
) against time (t, h
-1
) was 
determined in order to calculate the diffusion coefficient (D, mm
2 
h
-1
)
[70]
: 
𝐷 = (
√4
3
− 1
4 × ln 2
)
𝑛
𝑡
= 0.212
𝑛
𝑡
                                                   (5.1) 
   
6.1.7. Further Dosimetric Characterisation of Optimal Formulation 
Upon identification of the optimal formula, a more in depth characterisation of the gel 
dosimeter was performed. For reaction rate measurements, one cuvette was irradiated to 20 
Gy using the protocol outlined above for the dose response measurements. The irradiated 
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cuvette was scanned at room temperature every 10 minutes from 10 to 70 minutes post-
irradiation using the flatbed scanner. 
To determine the effects of varying dose rate and beam energy on the dose response, two sets 
of cuvettes were irradiated using the protocol outlined for dose response measurements with a 
10 MV photon beam and dose rate of 600 MU/min as well as with a 6 MV photon beam and 
dose rate of 400 MU/min. Both gel cuvette sets were irradiated from 0 to 32 Gy. Post-scans 
were performed with the flatbed scanner to obtain comparative dose response curves. 
 
6.1.8. Three-dimensional measurements 
To ensure the utility of the gel for three-dimensional dosimetry, a measurement was 
performed on a 375 mL PET jar containing the gel. The jar was irradiated with a 6 MV 
photon beam with an SSD of 100 cm and a dose rate of 600 MU/min. The jar received a dose 
of approximately 13 Gy in a 3 × 3 cm beam, horizontally through the centre of the jar. 
Readout was performed using a Vista optical CT scanner (Modus Medical Devices Inc., 
London, Canada), with an amber LED source (λ = 590 nm) and a pixel size of 0.5 mm.  
 
6.1.9. Gel Reusability 
The jar of gel used for 3D measurements was reused and the variation in its dose response 
was evaluated. To ensure uniformity of Fe
3+
 concentration throughout the gel, the jar was 
submerged in a bath of warm water at a temperature of approximately 40 °C for 10 minutes. 
Subsequently, a stirring bar was added to the mixture and stirring was continued for 10 
minutes until the colour of the gel was completely uniform. The gel was then poured into 10 
plastic cuvettes for a dose response evaluation and the remainder was kept in the PET jar to 
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evaluate the utility of the reused gel for 3D measurements. The dose response was evaluated 
using an identical method as outlined above for previous dose response measurements. The 
PET jar was irradiated and read out according to the protocol for 3D measurements detailed 
above. 
 
6.2. Results 
6.2.1. Dose response comparison 
The dose response of the six gel formulations was evaluated across the typical linear range of 
Fricke gel dosimeters.
[4, 88]
 Figure 6.2 displays a comparison of the dose response of all gel 
formulations from 0 to 32 Gy as measured with the flatbed scanner. As has been previously 
demonstrated,
[89]
 a reduction in the observed sensitivity is to be expected when using the 
broad spectrum of the flatbed scanner as opposed to the narrow wavelength conditions widely 
adopted for optical gel read–out, however this measurement technique is effective at 
determining the response linearity and providing a two-dimensional O.D. readout of gel 
cuvettes. The uncertainties displayed in figure 6.2 were calculated by propagating standard 
deviations of pre– and post–scan pixel values (from the scanner images) through OD 
calculations. 
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Figure 6.2: Dose response comparison of the six gel formulations from 0 to 32 Gy measured 
using the green channel of an Epson Perfection V700 flatbed scanner in absorption mode. 
The slopes were determined by least-squares linear regression. The plotted symbols indicate 
the uncertainty in the data points. 
 
O.D. sensitivities and linearity quality (r
2
) for the dose range 0 to 32 Gy are summarized in 
table 6.2 along with the background/baseline optical density for each gel. All gel 
formulations gave linear responses within the range tested, matching expectations based on 
literature understandings of Fricke gels.
[4, 88]
 Gels containing PVA as the gelling agent 
(formulation 3 and 4), showed significantly lower dose responses than the other formulations 
containing gelatin. Additionally, the background O.D. of the PVA gels is much higher than 
all other gel formulations. Comparing formulations 1 and 2, it is evident that the addition of 
glyoxal results in a small increase in O.D. sensitivity and a small decrease in the background 
O.D. of the gel. Based on the results of formulations 2, 5, and 6, reducing the concentration 
of xylenol orange - substituted PVA and Fe(SO4)2 significantly reduces the background O.D. 
of the gel while maintaining only a small reduction in O.D. sensitivity of the gel. Due to its 
H ello……is  it me you’re looking fo r?  
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increase in O.D. sensitivity relative to background O.D., it is apparent that formulation 6 has 
the optimal dose response properties of the gels compared. 
Formulation O.D. sensitivity 
(Gy
-1
) 
Linearity 
(r
2
) 
Background O.D. 
1 0.0034 0.9963 0.4850 
2 0.0035 0.9880 0.4839 
3 0.0017 0.9964 0.5830 
4 0.0012 0.9991 0.6092 
5 0.0033 0.9984 0.3732 
6 0.0031 0.9983 0.2592 
Table 6.2: The O.D. sensitivity, background O.D., and respective 
linearity quality for all gel formulations. 
 
6.2.2. Auto-oxidation comparison 
Figure 6.3 shows O.D. measurements of the non-irradiated gels plotted against time. 
Uncertainties in the OD values were calculated using the same method as outlined for dose 
response measurements.  
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Figure 6.3: The increase in O.D. of the six gel formulations as a function of time due to auto–
oxidation. The plotted symbols indicate the uncertainty in the data points. 
 
The auto–oxidation rate (h-1) is taken as the slope of the plot in figure 6.3. The highest auto-
oxidation rates are present in gels with higher concentrations of xylenol orange - substituted 
PVA and Fe(SO4)2
 
(0.4 mM), as formulations 1 to 4 have auto-oxidation rates of 0.00134 h
-1
, 
0.00118 h
-1
, 0.00115 h
-1
, and 0.00123 h
-1
 respectively. As this concentration reduces in 
formulations 5 (0.2 mM) and 6 (0.1 mM), so too does the auto-oxidation rate with values of 
0.00058 h
-1
 and 0.00023 h
-1
 respectively. Evidently, auto-oxidation is minimized by 
formulation 6. 
 
6.2.3. Diffusion rate comparison 
The methods outlined for diffusion measurements were carried out for all six gel 
formulations, however formulation 3 (i.e. 10% PVA gelling agent) failed to set and as such 
diffusion results are not displayed for this mixture. Figure 6.4 shows the plot of the curvature 
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parameter (n) against time (t) for gel formulations 1, 2, 5, and 6 over the period 1 to 105 
hours. Data for formulation 4 is only displayed over 50 hours due to limitations arising from 
the enhanced effects of auto-oxidation and scatter in this gel. After 50 hours, the effects of 
auto-oxidation in formulation 4, relative to its low dose response, result in a small O.D. 
variation between the irradiated and unirradiated sections of the gel cuvette. Additionally, the 
increased scatter in PVA gels results in a greater uncertainty in the measured O.D. across the 
cuvette particularly as the gel gets darker from effects such as auto-oxidation. Combining 
these effects, the diffusion profile becomes inefficiently resolvable relative to noise and 
measurements of the curvature parameter yield inaccurate results. 
 
Figure 6.4: Plots of the curvature parameter ‘n’ as a function of time for the various gel 
formulations. Inset: Curvature parameter ‘n’ plotted for the first 10 hours post-irradiation. 
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The lowest diffusion rate measured across the various gels was 0.103 ± 0.004 mm
2
 h
-1
 for 
formulation 4 (i.e. 20% PVA). This measurement was the only one taken for the reduced 
period of 50 hours, and despite this diffusion rate being very low, its dosimetric utility is 
greatly hindered for the aforementioned reasons. Of the remaining formulations, the gel with 
the highest diffusion rate is formulation 1 (i.e. 10% gelatin) with a diffusion rate of 0.239 ± 
0.002 mm
2
 h
-1
. The addition of glyoxal in formulation 2, resulted in a 21% reduction in 
diffusion with D2 = 0.190 ± 0.002 mm
2
 h
-1
. Similarly to dose response and auto-oxidation 
results, the best results were obtained with lower concentrations of xylenol orange - 
substituted PVA and Fe(SO4)2; formulation 5 (0.2 mM) yielded a diffusion rate of 0.146 ± 
0.001 mm
2
 h
-1
 and formulation 6 had a diffusion rate of 0.132 ± 0.001 mm
2
 h
-1
. 
 
6.2.4. Characterisation of Optimal Formula 
As demonstrated in the comparative results, formulation 6 optimizes the practicality of the 
gel for clinical use as an easy to produce gel with the lowest auto-oxidation rate, best 
response relative to background optical density and the lowest diffusion rate of all gelatin 
based gels. To further investigate its viability for clinical application, a more in depth 
characterisation of its dosimetric properties was conducted 
 
6.2.4.1. Dose response beyond linear range 
Figure 6.5 displays the dose response of gel formulation 6 from 0 to 107 Gy as measured with 
the flatbed scanner. The linear range of the gel doesn’t exceed the measured linear range in 
figure 6.2 (i.e. 0 to 32 Gy), in alignment with published investigations into Fricke gel dose 
responses.
[4, 88]
  Unlike other ferrous sulphate xylenol orange dosimeters which have been 
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published as reaching a saturation point at much lower doses,
[4, 69, 88, 89]
 the saturation point of 
the formulation 6 is not reached by the maximum dose of 107 Gy, however this is well 
outside the range of common treatment doses and is therefore not of concern to clinical 
dosimetry. Figure 6.5 also acts to demonstrates that formulation 6 is capable of resolving 
single grey doses. 
 
Figure 6.5: The optical dose response of gel formulation 6 beyond the linear response range 
from 0 – 107 Gy. The plotted symbols indicate the uncertainty in the data points. Inset: 
Optical dose response highlighted for the 0 to 10 Gy range. 
 
6.2.4.2. Reaction Rate 
Figure 6.6 shows the increase in O.D. of formulation 6 over time, immediately after 
irradiation to 20 Gy. These measurements were performed without any refrigeration of the 
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irradiated gels, due to the small time between measurements. The average O.D. increase as a 
function of time across this period is 0.00257 h
-1
 and is primarily caused by room temperature 
auto-oxidation. Compared to the data obtained from figure 6.4, where gel samples are stored 
at 2 °C between measurements (0.00023 h
-1
 auto-oxidation rate), the O.D. stability of 
formulation 6 stored at room temperature is approximately 11 times lower. Figure 6.6 
demonstrates that gel formulation 6 is sufficiently developed for read-out approximately 30 
mins after irradiation.  
 
 
Figure 6.6: O.D. of formulation 6 as a function of time after irradiation to 20 Gy. 
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6.2.4.3. Energy and dose rate dependence 
A comparison of dose responses of formulation 6 from 0 to 32 Gy for varying beam energy 
(6 MV vs 10 MV) and dose rate (400 MU/min and 600 MU/min) is plotted in figure 6.7 to 
evaluate the dependence of the gels dose response on these beam parameters. Regardless of 
dose rate or beam energy, all dose response curves show good linearity r
2
 > 0.998, however 
discrepancies do exist among measured O.D. sensitivities when varying these irradiation 
parameters. Maintaining a constant dose rate of 600 MU/min, while altering the beam energy 
from 6 MV (O.D. sensitivity: 0.0031 Gy
-1
) to 10 MV (O.D. sensitivity: 0.0023 Gy
-1
) reduces 
the measured dose sensitivity by approximately 26%. Keeping the beam energy consistent at 
6 MV, while changing the dose rate from 600 MU/min (O.D. sensitivity: 0.0031 Gy
-1
) to 400 
MU/min (O.D. sensitivity: 0.0029 Gy
-1
) has less impact, yet still reduces the average 
sensitivity over the measured range by 6%. For the varying dose rate measurements, all data 
points in the range 0 – 16 Gy have overlapping results, however as the dose increases, the 
effects of altering dose rate become more prominent until a distinct separation is evident. It is 
clear that some energy and dose rate dependence is present in the response of formulation 6. 
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Figure 6.7: O.D. Response of gel formulation 6 from 0 to 32 Gy comparing 6 MV and 10 MV 
beam energies along with dose rates of 400 MU/min and 600 MU/min. 
 
6.2.4.5. Three-dimensional measurements 
Qualitative measurements using a jar of gel formulation 6 irradiated with a simple 3 cm × 3 
cm beam provide some clarity on how the gel appears in a 3D environment. Figure 6.8 shows 
transmission images of the gel taken 1 hour after irradiation. The beam generates a strong, 
clearly visible colour change with well-defined field edges. 
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Figure 6.8: Transmission images taken in the Vista Optical CT scanner of jars filled with gel 
formulation F irradiated with approximately 13 Gy in a 3 × 3 cm beam. Images taken in 
planes perpendicular (A) and parallel (B) to the beam direction. The dashed line indicates 
the region in which slices are displayed in figures 6.9 and 6.11. 
 
After reconstruction of optical CT scans, cross beam slices of orthogonal dose planes through 
the isocentre were collected and are displayed in figure 6.9. These images give an excellent 
indication of the results obtainable using formulation 6 for 3D measurements. An additional 
scan of the irradiated gel was taken the following day, 18 hours after irradiation. Comparing 
slices across this time difference shows relatively low diffusion with minimal loss in dose 
information despite being measured well outside the recommended time period (1.5 hours) 
for post-irradiation read-out of commercially available gelatin based Fricke gels.
[90]
 
A B 
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Figure 6.9: Cross-beam slices from reconstructed 3D scans of gel formulation 6 taken 1 hour 
and 18 hours after irradiation along with corresponding dose profiles taken through these 
slices. The location of each slice is indicated by the dashed line as in figure 6.8. The location 
of the profiles is indicated by the solid lines. 
 
6.2.4.6. Gel Reusability 
The dose response of the reused gel is compared against that of a new batch from 0 to 32 Gy 
in figure 6.10. The reused gel has a 14% increase in its baseline O.D. from 0.2596 to 0.2963. 
This increase is due to thermal auto-oxidation of Fe
2+
 ions when melting and resetting the gel, 
1
 h
o
u
r 
p
o
st
 i
rr
a
d
ia
ti
o
n
 
1
8
 h
o
u
r 
p
o
st
 i
rr
a
d
ia
ti
o
n
 
121 
 
along with the dose information from the previous irradiation which has become uniformly 
distributed through the gel following the reuse procedure. The response of the reused gel 
remains linear in the dose range tested with r
2
 = 0.9982. Comparing the dose sensitivity of the 
two gels reveals a small difference, as the response of the reused gel (O.D. sensitivity: 0.0028 
Gy
-1
) is 10 % lower than the new gel (O.D. sensitivity: 0.0031 Gy
-1
). 
 
Figure 6.10: O.D. Response of gel formulation 6 from 0 to 32 Gy comparing fresh gel and gel 
reused by melting, stirring and resetting. 
 
Orthogonal cross beam slices taken from 3D measurements of the reused gel irradiated with a 
3 cm × 3 cm beam are displayed in figure 6.11. The slice location and measurement 
procedure is identical to that used for the results in figures 6.8 and 6.9. Similarly to the 3D 
measurements of a new batch of gel, the reused data gives a distinct O.D. change detectable 
by the optical C.T. scanner, even with the 10 % reduction in O.D. sensitivity. Once again, 
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comparison of these slices 1 and 18 hours after irradiation shows a minimal loss in dose 
information.  
 
 
 
 
 
Figure 6.11: Cross-beam slices from reconstructed 3D scans of reused gel formulation 6 
taken 1 hour and 18 hours after irradiation along with corresponding dose profiles taken 
through these slices. The location of each slice is indicated by the dashed lines as in figure 
6.8. The location of the profiles is indicated by the solid lines. 
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6.3. Discussion 
6.3.1. Practical considerations and effects of gelling agent 
It is well established that the gel forming material has a significant impact on the properties 
of the 3D Fricke dosimeter. In this study, the use of PVA as opposed to Gelatin results in a 
significant reduction in O.D. sensitivity as well as an increase in background O.D. (table 6.2). 
As suggested by Hill et al., one possible reason for the reduction in dose sensitivity may be 
that the excessive boiling time required to dissolve the PVA reduces the amount of dissolved 
O2 in the final gel, in turn reducing the dose response.
[25]
 Another reason for the reduction in 
sensitivity, which is unique to the system investigated here, stems from the incorporation of 
xylenol orange – substituted PVA into the PVA gel matrix.  As the functionalised molecules 
crosslink with the rest of the gel matrix, the effective molecule size increases dramatically. 
With this increased molecule size, alterations in the charge distributions become present 
which can have adverse effects on xylenol orange’s ability to chelate ferric ions, thus 
reducing the sensitivity of the gel. The increase in background O.D. can be attributed to the 
higher scatter in PVA gels along with a greater presence of macroscopic suspended particles. 
These effects also manifest as greater uncertainty in O.D. values stemming from lower signal 
to noise ratios.  
 
Another downside of using PVA as opposed to gelatin as a gelling agent arises from the 
manufacturing procedure. While gelatine is easy to work with, dissolving at relatively low 
temperatures (< 55 °C) in short periods (< 30 mins), producing gels from PVA is much less 
convenient, requiring high temperatures (up to 110 °C) and long dissolution times (up to 3 
hours). Additionally, the concentration required to manufacture effective PVA gels (20% 
w/v) is significantly higher than gelatin, resulting in a higher viscosity and therefore difficult 
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to manipulate solutions. As discussed by Peppas et al., the degree of crosslinking (and 
consequently scatter) present in the final PVA gel, is greatly dependant on the gel production. 
The time-temperature history of the preparation impacts the rate of crosslinking in PVA 
solutions, and as such it is important that the exact same procedure is followed for each PVA 
gel.
[91]
  
 
6.3.2. Effect of glyoxal 
The addition of glyoxal (formulation 2) to the gelatin based dosimeter (formulation 1) has a 
number of positive effects; it produces a small reduction in the background O.D. of the gel, 
reduces auto-oxidation by 12%, and reduces diffusion by 21%. The effects of glyoxal as an 
additive in the ferrous–xylenol orange–gelatin dosimeter have been investigated by Penev et 
al. with similar results.
[71, 75]
 Penev et al. state that the reduction in background O.D. and 
auto-oxidation can be attributed to glyoxal hemiacetals. These compounds, which are present 
upon the addition of glyoxal, can form colourless complexes with Fe
3+ 
ions. As a result, auto-
oxidation has a lower impact on the O.D. of the gel as only a fraction of Fe
3+
 is present as a 
coloured xylenol orange chelate. Glyoxal also acts as a cross-linker with gelatin, increasing 
the density of the gel matrix. For this reason, adding glyoxal to the gelatin based dosimeter in 
formulation 2 results in a reduction in diffusion. 
 
6.3.3. Diffusion rate 
The diffusion coefficient measured for a 20% PVA gel with the introduction of xylenol 
orange – substituted PVA (formulation 4) yielded a diffusion rate of 0.103 mm2 h-1. This is a 
37% improvement on the diffusion rate of a gel with the same PVA and Fricke solution 
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concentration (0.144 mm
2 
h
-1
) and a 20% improvement on the Fricke gel dosimeter 
incorporating partially functionalised xylenol orange – PVA (0.129 mm2 h-1).[69, 89] Despite 
this, the low dose response, high scatter, and manufacturing concerns involving PVA negate 
the practical benefits of lower diffusion and render the formulation inappropriate for clinical 
use.  
 
The diffusion coefficients of all gelatin based dosimeters tested (formulations 1, 2, 5, and 6) 
were lower than all previously published values for gelatin and agarose based Fricke gels 
ranging from 0.3 to 2.2 mm
2
 h
-1
.
[70, 72]
 Formulation 6 yielded the lowest diffusion rate (0.132 
mm
2
 h
-1
), with a 56% improvement over the best results of gelatin based gels and an 8% 
improvement over the 20% PVA Fricke gel.  
 
This is a significant improvement and is attributable to the integration of xylenol orange – 
substituted PVA in the dosimetry system. With this addition, all xylenol orange in the gel is 
bound to the much larger PVA molecule and therefore less able to diffuse. Contrary to the 
methods previously outlined incorporating xylenol orange functionalised PVA into the Fricke 
gel system,
[89]
 the synthesis method utilised in this work gives a quantitative yield of 
indicator molecules bound to the polymer. This was verified by dialysing xylenol orange – 
substituted PVA against water and ensuring that the filtrate showed no sign of unbound 
xylenol orange. Given that all the formulations tested (including PVA gels where cross-
linking would eliminate any diffusion of xylenol orange – substituted PVA) showed some 
degree of diffusion, the remaining instability in these gels can only be credited to dissociation 
of Fe
3+
 ions from xylenol orange which cannot be eliminated through polymer 
functionalisation. As such, the results presented in this work establish the maximum 
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reduction in diffusion that is achievable in Fricke hydrogels by chemically bonding polymers 
with chelators. 
   
6.3.4. Energy and dose rate dependence 
Measurements of the dose response of the optimised gel (formulation 6) with varying energy 
indicated some degree of energy dependence of the dosimeter (figure 6.7). This is at odds 
with conventional Fricke gel dosimeters which typically have a dose response which is 
independent of energy over a large range, from approximately 0.2 to 10 MeV.
[4]
 The 
alteration in this dosimetric property of the gel is unexpected and requires further 
investigation to be better understood. 
 
This study also revealed a small, 6% difference in dose sensitivity for photon beams between 
the dose rates 600 MU/min and 400 MU/min. Previous studies of agarose and gelatin based 
Fricke gel dosimeters showed no significant dose-rate dependence in their linear range of 
dose response.
[68, 92]
 Conversely, studies of polymer gels have found comparable or 
significantly higher dose rate dependence from 30 cGy/min to 400 cGy/min with the PAG, 
nMAG and nPAG gels showing differences of 12%, 66%, and 5% respectively over the dose-
rates tested.
[93]
 The existence of dose-rate dependence may provide limitations in the 
applications of a potential 3D dosimeter, as some treatments use varying dose-rates across 
deliveries/fractions. 
6.3.5. Reusability 
Using the melting and resetting procedure, the optimised gel (formulation 6) yielded 
excellent results upon reuse. Analysis of the dose response (figure 6.10) showed good 
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linearity upon the second irradiation with only a 10% decrease in the dose sensitivity from 0 
to 32 Gy. The results obtained here mirror those in an investigation of the impact of glyoxal 
on Fricke gels by Penev et al. which showed that adding the compound positively impacts the 
linearity of subsequent irradiations.
[71, 75]
 Additionally, the dose response of the gel presented 
here doesn’t reach saturation at high doses, even up to 107 Gy (figure 6.5). This is beneficial 
as it not only opens up the use of the dosimeter for high dose applications but also allows 
reuse of the gel multiple times and to high cumulative doses.  
 
6.4. Conclusion 
In this study, the ferrous sulphate – xylenol orange dosimeter is modified by incorporating 
xylenol orange-substituted PVA in order to minimize the diffusion of post-irradiation dose 
information. Unlike the initial work on the use of functionalised polymers in Fricke 
dosimeters (Chapter 4), the synthesis method applied in this investigation obtains a 
quantitative yield of reporter molecule – polymer bonding. As such, the results presented here 
represent the maximum attainable reduction of diffusion in Fricke gels using a functionalised 
polymer.  
 
The conducted experiments suggest that one formulation with a good compromise in dose 
sensitivity, background optical density, auto-oxidation rate, and diffusion coefficient contains 
10% (w/v) gelatin in a 50 mM H2SO4 aqueous solution, with 10 mM glyoxal, 0.1 mM ferrous 
sulphate, and 0.1 mM xylenol orange – substituted PVA. The optical dose response was 
found to be linear (r
2
 = 0.9983) from 0 to 32 Gy with a sensitivity of 0.0031 Gy
-1
 and the 
auto-oxidation rate was measured as 0.00023 h
-1
. The gel yielded a diffusion coefficient of 
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0.132 mm
2 
h
-1
 which is significantly lower than any previously published results for gelatin or 
agarose gels and even slightly lower than the result obtained for a 20% PVA Fricke gel. This 
is a substantial development as it combines low diffusion comparable to a PVA gel with the 
ease of preparation and reliable response of a gelatin Fricke gel. On top of this, melting and 
resetting of the gel demonstrated a continued linear response with only a 10% reduction in 
dose sensitivity. Although manufacturing the functionalised polymer in a clinical 
environment would be unviable, the availability of xylenol orange – substituted PVA from 
commercial chemical suppliers would provide a simple means to a low diffusing, reusable gel 
dosimeter.  
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Chapter 7 
 
Conclusions and recommendations 
 
 
This work set out to create a new gel dosimeter which solves the issues preventing these 
systems from clinical use; i.e. toxicity, oxygen sensitivity, instability. Based on an analysis of 
previously researched gels, it was determined that modifications to existing Fricke gel 
systems could provide an avenue to achieving this aim. Fricke gels have the advantage of no 
toxic ingredients, while still maintaining a high, linear, dose-rate and energy independent 
response with easy read-out via optical CT or MRI. The major issue limiting the practicality 
of the Fricke gel is spatial instability due to diffusion of dosimetrically active materials in the 
gel. Due to the manipulability of the Fricke dosimeter, this work sought to make 
modifications to some ingredients in the gel in an attempt to reduce the effects of diffusion. 
 
Before making modifications to the Fricke dosimeters, the third chapter of this thesis sought 
to optimise the accuracy of gel diffusion measurements. Typical measurements of diffusion 
involve a half-field irradiation of the gel, after which the ‘blurring’ across the interface of 
irradiated and non-irradiated gel is measured. To limit the baseline ‘blurring’ effect, 
measurements of half-field beam penumbra were taken using EBT2 film for a variety of 
blocking techniques. It was shown that minimizing the SSD reduces the penumbra as the 
effects of beam divergence are diminished. The addition of a lead block directly on the 
surface provides optimal results with a 10-90% penumbra of 0.53 ± 0.02 cm. Based on this 
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result, all subsequent diffusion measurements throughout the thesis utilised the lead block 
when performing the half-field irradiation. 
 
The fourth chapter comprising this thesis employed simple organic synthesis methods to 
partially functionalise PVA with the xylenol orange reporter molecule. This modification to 
the PVA Fricke gel was the first investigation into the effects of incorporating functionalised 
polymers into gel dosimeters. Two gels were prepared for comparative measurements; the 
PVA-FX gel as outlined by Chu et al., and a gel using PVA partially functionalised with 
xylenol orange. The new gel presented here was measured to have a linear OD dose response 
from 0 to 30 Gy (r
2
 = 0.9978) with a sensitivity of 0.014 Gy
-1
, an auto oxidation rate of 
0.0005 h
-1
 and a diffusion coefficient of 0.129 mm
2
 h
-1
 measured via optical CT. Although 
many dosimetric properties of this new gel deteriorated relative to the original PVA-FX gel, 
the diffusion parameter at the centre of the thesis showed good results, reducing by 8% 
compared to the PVA-FX gel. The deterioration of dosimetric properties, along with the 
limited reduction in diffusion, indicated that the functionalization method employed in this 
work yielded a low degree of xylenol orange integration in a largely impure product. 
Regardless, this first paper proved that the integration of functionalised polymers could be 
used to reduce diffusion in Fricke gel dosimeters, and with the development of more efficient 
functionalization methods, a clinically relevant system could be produced. 
 
Continuing from this initial investigation, the fifth chapter expanded the scope of chemistry 
used to more complicated methods in order to produce xylenol orange-substituted PVA as a 
pure compound. To achieve the target molecule, azide-functionalised PVA was produced 
using a relatively simple, modified literature procedure. Separately, modifications to the 
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production method of xylenol orange yielded alkyne-xylenol orange. Finally, a ‘click’ 
reaction (the Huisgen 1, 3-Dipolar Cycloaddition of alkynes and azides) was used to bond the 
two intermediates, completing the synthesis with a reliable, simple to perform, and easy to 
purify step. All compounds were well characterised with high quality 
1
H and 
13
C NMR 
spectra along with HR-MS or IR where appropriate. The methods here provide a means of 
efficiently bonding xylenol orange to PVA in high purity with good yields for most steps. On 
top of its use in gel dosimetry, this development may find application in other fields where 
the spatial stability of reporter molecules is a necessity. 
 
Using this synthesis, the resulting compound (xylenol orange-substituted PVA) was 
integrated into a Fricke gel dosimeter and investigated in the sixth chapter of this thesis. As 
the synthesis method obtains a quantitative yield of reporter molecule – polymer bonding, the 
results presented here represent the maximum attainable reduction of diffusion in Fricke gels 
using a functionalised polymer. Comparing formulations with varied gelling agents and 
additives, it was found that a gel with good auto-oxidation rate, strong response relative to 
background optical density and low diffusion could be made with a mixture of 10% (w/v) 
gelatin in a 50 mM H2SO4 aqueous solution, with 10 mM glyoxal, 0.1 mM ferrous sulphate, 
and 0.1 mM xylenol orange – substituted PVA. For summative purposes, table 7.1 (below) 
details the properties of this gel along with the best results from Fricke gels in this thesis and 
the literature. A major benefit of using gelatine as the gelling agent is the improvement in 
ease of use and preparation; while producing dosimeters in a PVA gel can be difficult and 
time consuming due to their viscosity, Fricke gelatine dosimeters dissolve and set much 
quicker making them significantly more desirable in a clinical setting. For the optimised 
system, the optical dose response was found to be linear (r
2
 = 0.9983) from 0 to 32 Gy with a 
sensitivity of 0.0031 Gy
-1
, the auto-oxidation rate was measured as 0.00023 h
-1
, and the gel 
132 
 
yielded a diffusion coefficient of 0.132 mm
2 
h
-1
. This diffusion result is significantly lower 
than any previously published results for gelatin or agarose gels and even slightly lower than 
the result obtained for a 20% PVA Fricke gel. In practical terms, this allows 2.3 times the 
stable scanning period relative to the best gelatine gel results in the literature. A reusability 
study of the dosimeter also showed positive results, as melting and resetting of the gel 
demonstrated a continued linear response with only a 10% reduction in dose sensitivity after 
a 13 Gy irradiation. This new gel dosimeter is a significant progression as it merges the ease 
of preparation and reliable response of a gelatin Fricke dosimeter with the benefits of low 
diffusion, characteristic of PVA gels. The method established to produce xylenol orange-
substituted PVA is laborious, however the availability of this compound from commercial 
sources would deliver a simple means to a low diffusing, reusable gel dosimeter. The 3D 
dosimetry system created here represents the final product of this work, and by alleviating the 
issues inhibiting gel dosimetry from routine use, the aim of the work has been achieved. 
Gel O.D. sensitivity 
(Gy
-1
) 
Auto-oxidation rate 
(h
-1
) 
Diffusion rate 
(mm
2 
h
-1
) 
PVA-FX  
(best literature PVA) 
0.0200 0.00005 0.141 
FX-G  
(best literature gelatine) 
0.034* 0.0024* 0.3* 
XO-PVA  
(Chapter 4 gel) 
0.0140 0.00050 0.129 
XO-sub PVA (10% gelatine) 
(Chapter 6 – formulation 6) 
0.0033 0.00023 0.132 
XO-sub PVA (20% PVA) 
(Chapter 6 – formulation 4) 
0.0012 0.00123 0.103 
Table 7.1: The O.D. sensitivity, auto-oxidation rate, and diffusion rate for key Fricke gels from 
this thesis and the literature. *Note that properties of the FX-G gel have been measured using 
different experimental set-ups to the other gels listed. 
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To expand the findings of this thesis and fill in some knowledge gaps, a number of 
recommendations for future work are listed below: 
 The MRI read-out properties of the xylenol orange-substituted PVA gel dosimeter 
(optimised gel from chapter 6) are not investigated in this thesis. In some cases, this read-
out modality may be preferable to optical CT, such as when gel containers are non-
cylindrical or made of opaque materials. Filling this knowledge gap would provide a basis 
for using the new gel for these applications and further demonstrate its robustness. 
 This work demonstrates that functionalised polymers can be used to reduce diffusion in 
gel dosimeters. In this thesis, Fricke gel systems were the focus of the work, however the 
integration of functionalised polymers could be extended to other 3D dosimeters (e.g. 
Micelle gels) which are often subject to spatial instability. 
 The issue of diffusion is addressed to great depth in this thesis, however auto-oxidation is 
still an ever-present issue in Fricke gel dosimeters that must be addressed. Work is 
constantly underway to solve this using various additives, but more extensive, chemical 
manipulation of ingredients (similar to the efforts of this work) has not been attempted in 
the pursuit reducing auto-oxidation effects.  
 Although the modifications present in the xylenol orange-substituted PVA gel dosimeter 
don’t significantly alter the density relative to a normal gelatine Fricke gel, the water 
equivalency should still be investigated and characterised. Monte Carlo simulations using 
the EGSnrc software should be used to calculate its radiological properties, such as mass 
and electron density, mass stopping powers, depth doses for kilovoltage x-ray and 
megavoltage electron beams etc. 
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Appendix A 
 
Initial Synthesis Methods 
 
 
This appendix comprises initial synthesis methods conducted with varying success, which led 
to the method in Chapter 4. 
 
Reaction A.1: Esterification of XO DS with 1–Butanol  
As shown below in figure A.1, the vinyl alcohol monomer is structurally and therefore 
reactively similar to 1–butanol. With this in mind, simplified experiments can be performed 
using 1–butanol to model how well a reaction will work when using PVA, without the 
complications of polymer crosslinking.  
 
 
 
To achieve the desired alteration, methods attempted to utilize the hydroxyl group, shared 
between 1–Butanol and PVA. Given the presence of two carboxylic acid groups in XO DS, a 
well-established esterification process was undertaken whereby butyl ester groups could be 
produced in place of the carboxylic acid groups when heated in the presence of an acid 
catalyst (i.e. HCl). The mechanism for the esterification reaction is detailed as follows:  
Figure A.1: Comparison of 1–Butanol and Poly(vinyl alcohol) molecules.  
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1. A proton (hydrogen ion) is taken from the concentrated Hydrochloric Acid, leaving 
chloride ion. This proton is attached to one of the lone pairs on the oxygen, which is 
double-bonded to the carbon. The transfer of the proton to the oxygen gives it a positive 
charge; however this charge is delocalized such that the carbon atom can also be charged. 
 
2. The positive carbon atom is attacked by the reacting alcohol, creating a tetrahedral 
intermediate, after which a hydrogen ion is lost at the location of the charged oxygen 
atom. 
 
 
 
 
3. A free proton then bonds to one of the lone pairs on the oxygen, forming water bonded to 
the central carbon atom. This water molecule is subsequently lost along with another 
hydrogen atom, as a double bond forms between the lone oxygen and central carbon.  
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The esterification of XO DS with 1–Butanol (Scheme A.1 shown below), was completed by 
reacting one equivalence each of xylenol orange and 1−Butanol, with 10 equivalents of HCl 
in an aqueous solution. The reaction vessel was prepared before being heated to 120 °C with 
magnetic stirring overnight. Examination of the product showed poor results with an 
inconsistent precipitate that was insoluble in numerous common solvents.  
 
 
 
 
 
Reaction A.2: Cyclic Anhydride Formation on XO DS 
Following similar work completed by Virta et al.,
[94]
 Reaction A.2 set out to make a cyclic 
anhydride on the XO DS molecule with Diisopropylcarbodiimide (DIC), using 
Dimethylformamide (DMF) as a solvent. The formation of a cyclic anhydride from two 
carboxylic acid groups is as follows: 
1. A negatively charged oxygen ion is formed when a carbonyl group is protonated. This 
charged ion is then attacked by the other carboxyl group’s hydroxyl oxygen. 
Scheme A.1: Production of Xylenol Orange monobutyl−ester from Xylenol Orange 
Disodium Salt with 1−Butanol and Hydrochloric Acid. 
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2. A free proton then bonds to one of the lone pairs on the hydroxyl oxygen, forming water 
bonded to the central carbon atom. This water molecule is subsequently lost, as a double 
bond forms between the lone oxygen ion and carbon. 
 
Cyclic anhydride formation (Scheme A.2 as below) was conducted by reacting XO DS and 
DIC in a molar ratio of 1:2, using (at first) DMF as a solvent. However, difficulty was 
encountered when trying to dissolve the XO DS in the DMF, so some Dichloromethane 
(DCM) was added to encourage solution. The reaction was run overnight with a stirring 
magnet, yet the xylenol orange still failed to completely dissolve. To determine if any 
desirable constituents were produced from the reaction, column chromatography was 
performed on the sample. Silica gel was used as the solid phase while the eluent comprised a 
mixture of 1% water, 99% ethanol. In order to dissolve some insoluble fragments, a small 
amount of water was used; however this resulted in the sample running through the column 
too fast and thus poor separation. A TLC of the fractions obtained compared to XO DS 
showed no distinction between the two, indicating the experiment was unsuccessful. 
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As a salt, the XO DS’s sodium atoms form an ionic bond with the 𝐶𝑂2
⊖
. As a result, these 
bonds are highly polar and thus the entire molecule will be inclined to dissolve in polar 
solvents like water. It was therefore concluded that the molecule needed to be altered to 
dissolve in a more polar solvent (DMF). 
 
Reaction A.3: Xylenol Orange Tetra-Acid 
To attain the desired solubility alteration to the XO DS molecule, it was supposed that the 
sodium carboxylate groups on the molecule could be replace by carboxylic acids. These 
functional groups would replace the ionic bonding Na atoms with covalent bonds between 
Oxygen and Hydrogen atoms, developing a less polar molecule capable of better dissolving 
in organic solvents (i.e. DMF etc.). 
 
 Xylenol Orange Tetra−Acid (XO TA) was produced via a substitution reaction between XO 
DS and Hydrochloric Acid (Scheme A.3 above). The process was initiated by dissolving XO 
DS in a minimum of water, then adding 2 equivalence of 2M HCl. Next, the sample was 
magnetically stirred for 30 minutes before being lyophilised for 2 days. The resultant sample 
Scheme A.1: Production of Xylenol Orange Cyclic Anhydride from Xylenol Orange 
Disodium Salt with DIC, DCM and DMF. 
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Scheme A.3: Formation of Xylenol Orange Tetra−Acid for Xylenol Orange Disodium Salt 
and HCl. Note the opening and closing of the oxidative ring between forms of the 
molecule. 
was a dry, orange precipitate viable for use in future reactions. It must be noted that this 
sample used for experiments also contained a quantity of NaCl (approximately 15% by 
mass). 
 
Reaction A.4: Esterification of XO TA through a Cyclic Anhydride Reaction 
Intermediate 
Following the process outlined for Reaction A.2, formation of cyclic anhydride on XO TA 
could be performed. However, with the successful solubility of XO TA in DMF, a second 
step could be added, employing 1−Butanol to achieve esterification of the XO cyclic 
anhydride compound. While the formation of the cyclic anhydride is outlined in section A.3., 
the mechanism of the subsequent esterification is outlined below: 
1. An oxygen atom is protonated via a lone electron pair while its bonded carbon atom is 
attacked by the reacting alcohol, creating a tetrahedral intermediate.  
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2. The oxygen atom in the ring is then protonated, giving it a positive charge. In the reacting 
alcohol, the bonded oxygen ion loses its charge by releasing a hydrogen ion.  
 
3. The oxygen ion in the ring loses its charge by breaking its bond to the tetrahedral 
carbinol. The hydroxyl oxygen atom forms a double bond with the carbon atom.  
4. The oxygen ion releases a proton to lose its charge. 
 
 
 
 
 
The esterification of XO TA through a cyclic anhydride intermediate (Scheme A.4 below) 
was conducted by reacting XO TA and DIC in a molar ratio of 1:2, using DMF as a solvent. 
Once dissolved, one equivalence of 1−butanol was added to the reaction vessel and it was 
stirred overnight. Following this time, tetrahydrofuran (THF) and diethyl ether was added to 
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Figure A.2: NMR spectrum of XO TA. 
the sample to form a precipitate. This product was freeze-dried and NMR spectroscopy was 
performed using deuterium oxide (D2O) as a solvent.  
 
 
 
 
 
 
Scheme A.2: Esterification of XO TA through a Cyclic Anhydride Reaction 
Intermediate using DIC and 1−Butanol in DMF. 
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Figure A.3: NMR spectrum taken on the product of Reaction A.4. 
A comparison of the spectra shown in figures A.2 and A.3 shows three new peaks evident in 
the product of reaction A.4 at shifts of 2.536, 2.669, and 2.825 ppm. As these peaks are 
known to correspond with DMF (the solvent used in the reaction), it was clear that small 
amounts of this solvent were not effectively removed post-reaction. With no other changes 
present, the desired product is certainly not present and therefore the method was 
unsuccessful. 
 
Reaction A.5: Esterification of XO TA/DS through a Benzotriazole Reaction 
Intermediate 
Similar to Reaction A.4, this reaction endeavoured to make an active ester through an 
intermediate. The experiment was derived from work completed by Goodey et al. in which 
dyes (including XO) were bonded to polymeric microspheres.
[87]
 Rather than using cyclic 
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anhydride as a leaving group for esterification, benzotriazole was to be bonded at the location 
of carboxylic acid groups in XO via the hydroxyl group in hydroxybenzotriazole (HOBT). 
The mechanism of this reaction is mostly similar to those previously outlined (for Reaction 
A.2 and A.4). Due to the precedence of dyes being bonded to polymers (in the work of 
Goodey et al.), an attempt was made to directly link the XO molecule to the PVA in this 
experiment, as opposed to using 1−butanol as a model. 
 
Reaction A.5 was commenced by washing the purchased PVA with DMF, THF, and diethyl 
ether while under an atmosphere of argon. Using two separate flasks, XO DS and XO TA 
were individually reacted with both DIC and HOBT in a molar ratio of 1:1:1. Both reactions 
were conducted under argon using DMF as a solvent. The samples were stirred for 15 
minutes in an ice bath, followed by another 15 minute at room temperature. To each flask, 4 
grams of washed PVA was added, after which both were allowed to stir for 5 days. The 
resulting solid phase was filtered and washed with water until the filtrate showed no 
characteristic colour of XO. Each solid was then freeze-dried for 3 days. Without adding any 
more XO, the XO DS PVA and XO TA PVA compounds were mixed to make 20% PVA 
gels, in 50 mM H2SO4 with 0.4 mM ferrous sulphate.  
 
Optical CT examination of these gels after a 20 Gy irradiation confirmed that no radio-
induced OD difference existed in either of the gels. It was therefore concluded that linking 
the PVA to XO through the benzotriazole reaction intermediate resulted in a molecule that no 
longer coordinated the ferric ions. As a result, no further investigation of diffusion in this gel 
could be conducted and the synthesis method in focus was considered unviable. 
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Reaction A.6: Diazonium Salt Mediated Arene Substitution 
Unlike reactions A.1 to A.5, this method doesn’t approach the XO – PVA bond via the 
carboxylic acid groups, but rather through a bond to the sulfonylated oxidative ring bonded 
benzene. Reaction A.6 follows the research of Fan et al. whereby xylenol orange 
functionalized silica gel was manufactured using a diazonium compound.
[76]
 In this reaction, 
para−amino benzoic acid was used as a model for PVA, similar to the use of 1-Butanol in 
previous experiments. 
 
The experimental method for Reaction A.6 was initiated by diazotizing 1.4 mmols of para-
amino benzoic acid with NaNO2 (20 mL of 2% (w/v)) in acetic acid (1%). After 1.5 hours, 
Scheme A.3: Esterification of XO TA/DS through a Benzotriazole Reaction 
Intermediate using DIC and HOBT in DMF. Note that the reaction above is only 
shown for XO DS, the esterification follows the same process for XO TA. 
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approximately three quarters of the water was evaporated using a rotary evaporator, while 1.4 
mmols of XO DS was dissolved in 50 mL of water. The diazotized para-amino benzoic acid 
was cooled below 5 °C until the solution formed a precipitate. The solid was filtered, added 
to the XO DS solution and allowed to stir for 2 days. To remove the water solvent, the 
solution was run through the rotary evaporator and freeze dried overnight. NMR 
spectroscopy was completed on the performed complex using D2O as a solvent.  Referring to 
Figure A.2, two new doublet peaks (at 6.705 and 6.726 ppm along with 7.599 and 7.621 ppm 
respectively) which are only evident in the product’s spectrum correspond to diazotized para-
amino benzoic acid. This does indicate that as desired, this molecule has bonded to XO DS. 
The success of this model experiment provides a basis for the method investigated in Paper 1.  
 
 
Figure A.4: NMR spectra comparison from ≈ 6.5 – 7.9 ppm for (top) Reaction 6 product, (bottom) 
Xylenol Orange Disodium Salt. 
